Huberman Lab Daily Notes

Independent video index & transcripts

← All transcripts

How Your Immune System Works & How to Improve It | Dr. Max Krummel

Watch the original on YouTube ↗

My guest is Dr. Matthew (Max) Krummel, PhD, professor at UCSF and one of the world’s leading immunologists. We discuss how your immune system works and how sleep, emotions, and even memories shape immune function. We also explore thymus function, its role in autoimmunity, and its potential role in combating cancer. And we discuss how the type and timing of immunization can impact health. This episode provides an actionable framework for understanding how your immune system works, which ought to benefit people of all ages and health statuses. Show notes: https://go.hubermanlab.com/zKNruC3 Pre-order Protocols: https://protocolsbook.com Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Joovv: https://joovv.com/huberman Follow Huberman Lab Website: https://www.hubermanlab.com Instagram: https://www.instagram.com/hubermanlab Threads: https://www.threads.net/@hubermanlab X: https://x.com/hubermanlab Facebook: https://www.facebook.com/hubermanlab TikTok: https://www.tiktok.com/@hubermanlab LinkedIn: https://www.linkedin.com/in/andrew-huberman Timestamps 00:00:00 Max Krummel 00:02:18 Immune System, Immunotherapy 00:08:36 Illness, Childhood & Immune System 00:13:02 Aging & Immunity, DNA Mutations 00:18:36 Sponsors: Joovv & Eight Sleep 00:21:14 Self vs Non-Self Recognition, Aging, Cancer; Immune Surveillance 00:30:11 Cancer, Immune System, Age & Measuring Change 00:35:57 Thymus, T Cells; Aging & Cancer 00:42:13 Reproduction, Aging & Immune System; Basic Research 00:47:28 Sleep & Illness Susceptibility 00:52:55 Sponsor: AG1 00:54:08 Umbilical Cord Banking; Organoids, CAR T Cells, Thymus 01:02:57 Scientific Curiosity, Failures, & Discovery 01:13:14 Spatial Biology & Immune Cells; Memory & Immune State; Stress, Meditation 01:25:00 Sponsor: Function 01:26:37 Mindset; Tissue Engineering, Peptides, Systems Biology 01:34:25 Immunizations in Childhood and Beyond 01:39:37 Pharmaceutical Companies, Public Distrust 01:49:22 Disease Risk, Immunity; Autism, Flu, 01:58:56 Biological Resilience, Cancer; Computational Research 02:08:02 Autoimmune Conditions, Asthma, IBD 02:13:34 Autoimmunity & Genetic Diversity Benefits 02:17:11 Science Communication, Max's Substack 02:24:07 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter #hubermanlab #hubermanlabpodcast Disclaimer & Disclosures: https://www.hubermanlab.com/disclaimer

AI Summary

English

Overview

Andrew Huberman speaks with UCSF immunologist and cancer biologist Dr. Max Krummel about the immune system as a distributed, adaptable sensory and maintenance network—not merely a defense against pathogens. They discuss immune development and aging, cancer surveillance, sleep, the thymus, tissue organization, brain–immune communication, vaccines, experimental peptides and stem-cell technologies, scientific discovery, pharmaceutical incentives, and autoimmune disease.

Krummel argues that immune function is continuously tuned between tolerance and attack. Immune cells monitor the molecular state of tissues, manage resident microbes and latent viruses, remove damaged material, support repair, and sometimes perpetuate chronic disease by applying an otherwise useful program in the wrong context. This broader understanding grew partly from AIDS research and cancer immunotherapy, which demonstrated both the importance of T cells and the possibility of adjusting immune activation.

The recurring theme is context: an immune signal or treatment may help only at the correct dose, location, time, and sequence. Krummel favors better data, transparent uncertainty, and foundational health practices over claims that a single drug, peptide, supplement, or longevity intervention can solve a complex biological problem.

Key ideas

- The immune system is both defensive and supportive. It regulates microbes in the gut, helps clear cellular byproducts in the brain, heart, liver, eyes, and other tissues, contributes to repair, and continually measures whether molecular signals remain within an acceptable range.

- Humans contain roughly \(10^{11}\) T cells, described as individual “free agents” carrying different receptors. Each samples peptides and other molecular signals and can respond when something appears out of range. Immune cells also communicate, form synapse-like contacts, and assemble local multicellular clusters resembling small information-processing networks.

- HIV revealed the immune system’s breadth by infecting and depleting CD4 T cells. During the AIDS epidemic, patients became vulnerable to ordinarily harmless environmental microbes, opportunistic cancers such as Kaposi sarcoma, and neurological problems. This helped establish that immune competence matters far beyond conventional infections.

- Humans are biological ecosystems. Microbes covering the skin and inhabiting the gut contribute genes and metabolic capabilities that the approximately 20,000 human genes alone do not provide. Gut microbes help process nutrients, including components involved in bile acids and the digestion of animal fats; some populations acquire microbial functions that help process seaweed.

- Early immune development involves both restraint and learning. Krummel says immunity is relatively difficult to train during roughly the first six months, perhaps because rapid developmental changes could otherwise be mistaken for foreign material. Children subsequently become sick often because most pathogens are new to them, although their vigorous immune systems usually clear infections quickly. Dangerous infections such as measles, mumps, and rubella are reasons for childhood immunization rather than relying on natural exposure.

- Aging reduces immune-cell production and function, while the body itself becomes increasingly heterogeneous. DNA replication errors, environmental exposure, and clonal selection make older tissues genetic mosaics rather than collections of identical cells. Krummel cites an estimate of 10,000–30,000 mutations per skin cell per day, while emphasizing that the genome is enormous and exact numbers are less important than cumulative divergence.

- This mosaicism complicates self-versus-nonself discrimination. Krummel compares it to wartime submarines using sound-profile books to distinguish friendly from enemy engines: as the body accumulates more variants, its “self” reference book becomes crowded, making malignant or infected cells less conspicuous against the background noise.

- The immune system likely eliminates many abnormal cells before they become tumors. Krummel suggests that some small white skin patches appearing in middle age may represent sites where immune cells removed potentially precancerous melanocytes. However, tissue repair selects for cells that divide efficiently; the same growth advantage that closes wounds can, if pushed too far, support cancer and metastasis.

- Cancer commonly develops slowly. Unlike an acute viral infection, which produces a rapid rise in foreign molecules plus tissue damage, a tumor may increase gradually enough for the immune system to accommodate it as part of the body’s normal state. Cancer immunotherapy can overcome some of this tolerance by altering activation thresholds or blocking inhibitory pathways.

- The immune system does not always seek complete sterilization. Many viruses leave material behind or persist latently. Killing every infected cell could be worse than tolerating dormant virus, especially when irreplaceable cells such as neurons are involved. Herpes-associated pain and injury can partly reflect immune attack on virus-bearing neural tissue rather than damage caused solely by the virus.

- The thymus creates and educates T cells. Bone-marrow-derived precursors enter it, generate an enormous diversity of receptors, and are screened so strongly self-reactive cells do not emerge to attack organs. The “T” in T cell originally referred to thymus.

- Krummel highlights Jacques Miller’s work: after physicians observed severe infections in children whose unexpectedly large thymuses had been removed during heart surgery, Miller removed the thymus from newborn mice. The animals developed profound infection susceptibility and sometimes tumors, helping demonstrate the organ’s central role.

- The thymus is large and highly productive in infancy and childhood, then involutes and becomes very small with age. Restoring thymic output might someday provide new T cells for cancer or age-related immune decline, but banking thymic tissue would require invasive surgery and has no established longevity application. Creating thymic epithelial scaffolds may ultimately be more useful than storing a piece of thymus.

- Sleep appears to provide an immune and metabolic maintenance period. During sleep, many immune cells return to bone marrow, while neutrophils enter tissues and may deposit collagen. Immune activity becomes reorganized or quieter, potentially permitting repair and clearance of energetic byproducts. Sleep also supports lymphatic drainage; Huberman attributes under-eye swelling and glassy eyes after sleep loss partly to impaired lymph clearance.

- The complete mechanism linking a night or two of poor sleep to infection susceptibility remains unsettled. Krummel says several research groups offer competing explanations, although nocturnal immune-cell migration is relatively well supported. Sleep should therefore be treated as important without pretending that one pathway fully explains its immune effects.

- Immune anatomy includes both migration and residency. Some cells circulate through blood, tissues, lymphatics, and lymph nodes, while resident populations remain in particular organs and provide local defense or support. A transplanted tissue must obtain blood flow, growth factors, lymphatic drainage, and sometimes neural input, while also avoiding immune rejection.

- Tissue context and spatial gradients matter. In wound healing, cells at the wound edge and cells farther away receive different signals and perform different tasks. A peptide, engineered cell, or drug given everywhere at once may disrupt this organization even if it has a beneficial effect in one location or phase.

- Genetically engineered cells may become immunologically foreign because viral vectors, plasmids, or newly expressed proteins give them a new molecular identity. This is an obstacle for tissue engineering and transplantation, even when the starting cells came from the patient.

- Umbilical-cord blood contains blood-forming stem cells and is relatively easy to collect because the cord would otherwise be discarded. Such cells can, in principle, restore blood formation after radiation or treatment for bone-marrow cancer. Krummel favors banking when affordable but admits he does not know whether commercial private banking has demonstrably saved someone who otherwise would have died. His strong suggestion that stored cord cells “would cure” childhood leukemia is therefore more confident than the evidence he personally cites.

- Induced pluripotent stem cells made with Yamanaka factors and organoids may eventually support replacement organs or personalized drug testing. Krummel thinks the more immediate problem is whether laboratory differentiation truly reproduces a functional organ, not merely whether the original fibroblast carried mutations. Timelines remain unpredictable: California’s regenerative-medicine initiatives produced substantial knowledge but fewer near-term therapies than hoped.

- CAR T cells and other engineered T-cell approaches illustrate this uncertainty. They can be designed to recognize tumors, but solid tumors often disable or exhaust them. Despite years of optimism, many applications have repeatedly failed to eliminate tumors in patients.

- Krummel’s graduate work in James Allison’s laboratory helped launch checkpoint cancer immunotherapy. After showing that blocking a T-cell molecule increased activation, he injected the antibody into tumor-bearing mice and saw tumors regress. That curiosity-driven experiment contributed to work for which Allison later received the Nobel Prize. The same immune amplification improved vaccination in models, worsened multiple sclerosis, and attacked tumors—showing that “more immunity” is not universally better.

- Breakthroughs often arise from basic research unrelated to the eventual application. CRISPR emerged from studying bacterial defense; X-rays arose from physics; GLP-related obesity drugs trace partly to research on the Gila monster; regeneration research, including Elly Tanaka’s work on salamanders, may inform future therapies even when translation is slow. Krummel argues that many failed or apparently trivial experiments are necessary because genuinely new discoveries are absent from existing knowledge.

- Machine learning can map relationships among genes, immune cells, fibroblasts, epithelial cells, and other tissue features, helping researchers propose experiments. Current AI is strongest at recombining an existing corpus, whereas discovery often concerns what is not yet in that corpus. Expensive biological experiments and human judgment remain necessary.

- Krummel describes recurring multicellular tissue configurations as “archetypes,” analogous to teams running different plays. Changing disease may require a sequence of nudges: dismantling a tumor’s wound-healing environment, altering particular cell populations, and only then teaching immunity to kill it. A single intervention may fail because biological systems are resilient and compensate.

- Brain states can influence organ-specific immune states. Krummel cites work from an Israeli group associated with Roy Slab in which researchers induced intestinal inflammation in mice, tagged insular-cortex neurons active during illness, allowed recovery, and later reactivated those neurons. Immune cells then began reassembling in the gut in a pattern resembling the original inflammatory state, although less strongly.

- This suggests that the brain may store aspects of bodily immune states alongside contextual memories. Recalling a context, smell, or emotional state might partially reinstate associated physiology through autonomic pathways, including the vagus nerve. Krummel and NYU physician-scientist Dan Littman discuss meditation as a possible way of shifting these networks toward less inflammatory states, but Krummel stresses that the idea is plausible and emerging—not an established clinical protocol.

- Immune molecules can alter behavior. Huberman cites experiments in which administering an infection-related inflammatory signal to otherwise uninfected mice produced social withdrawal, and notes that the brain carries receptors for immune signals. Maternal immune activation is also used experimentally to produce autism-like developmental changes in mouse offspring, demonstrating that inflammation can affect the developing nervous system.

- That animal model does not establish that vaccines cause autism. Krummel lists multiple alternatives: maternal infection, fever, vaccine-related inflammation in a susceptible context, or simple coincidence because developmental differences become visible around ages when vaccines are administered. His position is that neuroimmune effects are biologically possible but causal claims require much better human data.

- On vaccines, Krummel distinguishes general benefit from questions about timing, combinations, and communication. He vaccinated his children and considers the risk–benefit balance strongly favorable, particularly given the severe consequences of smallpox, measles, mumps, and similar diseases. He regards the resurgence of measles as alarming.

- He nevertheless agrees that original vaccine studies may not have tested every modern combination or spacing schedule. He once delayed a daughter’s vaccination by about a month because she was unwell and notes that slightly different schedules can still protect animals. Standard schedules improve adherence, statistical confidence, and convenience, but are not necessarily the only effective schedules.

- Krummel describes the shingles vaccine as heavily adjuvanted and personally incapacitating for a period, while saying he does not know whether that intensity is necessary. He supports transparent comparative studies of alternative combinations and schedules rather than dismissing reasonable questions or abandoning vaccination.

- Vaccine hesitancy involves science, personal autonomy, history, trust, and institutional incentives. Parents who perceive a dramatic change after vaccination may experience grief, guilt, and anger because they chose the intervention intending to help. Temporal association alone does not prove causation, but contemptuous or coercive communication intensifies distrust.

- Scientific institutions are not socially neutral. The Tuskegee study continues to shape distrust among Black Americans. Krummel argues that scientists must communicate as people, explain uncertainty in accessible language, and acknowledge institutional history rather than expecting credentials alone to produce trust.

- Pharmaceutical companies produce lifesaving medicines, and Krummel says most scientists and industry researchers genuinely seek to help. Corporate incentives can nevertheless diverge from patient interests. He uses checkpoint therapy for melanoma as an example: if a drug cures roughly 50% of patients but there is no test identifying responders, everyone receives it; a company may have little commercial incentive to develop a test that halves its market.

- Self-experimentation with unapproved internet peptides or other substances is risky because physical interventions can cause irreversible harm, dosing and purity may be unknown, and anecdotes do not establish causation. Krummel is not categorically against experimentation but wants preclinical and clinical evidence, systematic data collection, and context-specific evaluation.

- Autoimmune diseases can be understood as immune programs deployed against the wrong target or in the wrong tissue. Some have genetic components: Krummel describes familial lupus-associated defects in inhibitory B-cell receptors that permit excess autoantibody production.

- Asthma is not one uniform disease but a shared symptom—difficulty breathing—with perhaps seven or eight immune configurations. Different cases may be driven by pollen, chlorine, cold, eosinophils, neutrophils, or other pathways, explaining why an inhaler or immune treatment can work for one person but not another.

- Psoriasis, lupus, inflammatory bowel disease, and other autoimmune conditions also contain distinct immune subtypes. TNF-blocking drugs can dramatically help some inflammatory-bowel-disease patients, but clinicians cannot reliably predict response, and benefits may disappear over time, leading to sequential “whack-a-mole” treatment.

- Some disease-associated immune traits may provide benefits in another environment. Huberman proposes that mild psoriasis or heightened IL-17-related activity could trade skin inflammation for better pathogen resistance. Krummel supports the general evolutionary principle that population diversity preserves traits that may become useful under different conditions.

- Krummel illustrates this with bacteria: the fastest-growing cells in glucose may lose when moved to galactose, while previously slow “losers” become winners. He also invokes the malaria protection associated with sickle-cell variants, although the conversation incorrectly conflates sickle-cell disease with hemophilia.

- Individual nutrient needs may differ substantially because metabolic enzymes vary genetically. Regulatory intake values are population averages; Krummel speculates that some individuals might need several-fold more or less of a nutrient. This does not validate indiscriminate supplementation, which Huberman characterizes as scattershot.

Practical takeaways

- Protect regular sleep. It supports immune-cell trafficking, tissue repair, lymphatic clearance, and metabolic cleanup even though the complete mechanism is unresolved.

- Treat health as a coordinated system: sleep, exercise, nutrition, circadian light exposure, stress management, close relationships, and social connection create the background in which drugs and immune interventions operate. “Better living through chemistry” still requires better living.

- Do not assume stronger immune activation is always desirable. The same amplification can improve infection or tumor control while worsening autoimmunity, inflammation, or tissue injury.

- Discuss vaccine timing or temporary delays with a qualified clinician, especially when a child is acutely unwell. Do not infer that scheduling uncertainty negates the strong protection vaccines provide against serious disease.

- Be cautious with unapproved thymic peptides, internet-sourced compounds, implanted tissues, and other self-experiments. The relevant dose, purity, location, timing, immune compatibility, and long-term risks may be unknown.

- Cord-blood banking may be reasonable when collection and ongoing storage costs are acceptable, but families should ask providers for documented clinical utility rather than relying on hypothetical future cures.

- Evaluate supplements and immune treatments as individualized hypotheses, not universal solutions. A personal improvement may reflect the intervention, chance, expectancy, another simultaneous change, or natural fluctuation.

- For asthma, psoriasis, inflammatory bowel disease, lupus, cancer, or other immune-mediated illness, expect biological subtypes and variable treatment response. Work with clinicians to reassess therapies rather than assuming one drug’s failure disproves the entire treatment category.

- Mental practices such as meditation may influence autonomic and immune states, but memory-triggered immune control is still an emerging research area. It should complement, not replace, established care.

- When evidence is sparse, ask what experiment would distinguish competing explanations. Separate plausible mechanisms, correlations, animal findings, anecdotes, and demonstrated human outcomes.

Caveats and limits

- Much of the discussion is conceptual, based on animal studies, emerging spatial biology, or expert interpretation rather than completed human clinical trials.

- Krummel repeatedly distinguishes what is established from what he finds plausible. Mechanisms connecting sleep loss to infection, deliberate recall to beneficial immune states, thymus restoration to longevity, and stem-cell banking to future cures remain incomplete or uncertain.

- Mouse maternal-immune-activation models demonstrate that inflammation can alter neurodevelopment; they do not demonstrate that routine vaccination causes autism in humans.

- Vaccine adverse events can occur, but anecdotes and temporal proximity cannot establish causality. Conversely, uncertainty should not be used to dismiss sincere reports or prevent better safety and scheduling studies.

- Restoring or amplifying immunity carries trade-offs. New T cells could attack tumors but might also target self; checkpoint therapy can cure some cancers but harm normal tissues; blocking inflammatory pathways can relieve autoimmunity while potentially reducing infection defense.

- Tissue engineering is constrained by vascular supply, lymphatic drainage, growth signals, neural context, spatial gradients, and immune tolerance. Successful growth of tumors or tissue fragments in mice does not establish a safe human transplantation protocol.

- Predictions about regenerative medicine, organoids, CAR T cells, peptides, and longevity are especially vulnerable to hype. Scientific advances may arrive suddenly, but neither researchers nor consumers can know whether they will arrive in time for a particular person.

- Several numerical and medical statements are presented conversationally and should not be treated as clinical guidance. The transcript’s linkage of sickle-cell disease with hemophilia is incorrect, and its claim that privately banked cord blood would cure childhood leukemia is more categorical than the evidence discussed supports.

- Regulatory nutrient recommendations are averages, but the suggestion that individuals may need five times or one-fifth of a given amount is illustrative, not a dosing protocol.

- Scientific papers often emphasize possible importance or future extensibility to attract attention. “May matter for” is not the same as “has been shown to cause or cure.”

- Institutional, commercial, and political incentives can shape research and communication, but this does not justify rejecting science, vaccines, pharmaceuticals, or medicine as a whole. Krummel’s preferred response is more transparent data, better-designed experiments, acknowledgment of incentives, and nuanced public communication.

中文翻译

概述

Andrew Huberman 与加州大学旧金山分校免疫学家兼癌症生物学家 Max Krummel 博士讨论了免疫系统:它是一个分布式、可适应的感知与维护网络,而不仅仅是抵御病原体的防御系统。他们探讨了免疫系统的发育与衰老、癌症监视、睡眠、胸腺、组织结构、脑—免疫沟通、疫苗、实验性肽与干细胞技术、科学发现、制药行业的激励机制以及自身免疫性疾病。

Krummel 认为,免疫功能会在耐受与攻击之间持续调整。免疫细胞监测组织的分子状态,管理常驻微生物和潜伏病毒,清除受损物质,支持修复;有时,它们也会因为在错误的情境中执行了原本有益的程序而使慢性疾病持续存在。人们对免疫系统的这种更广泛理解,部分源于艾滋病研究和癌症免疫疗法;这些研究既证明了 T 细胞的重要性,也表明调整免疫激活是可能的。

反复出现的主题是情境:一种免疫信号或治疗,可能只有在剂量、位置、时间和顺序都正确时才有帮助。相比声称某一种药物、肽、补充剂或长寿干预就能解决复杂生物学问题,Krummel 更重视更好的数据、对不确定性的透明说明以及基础健康实践。

关键观点

- 免疫系统既具有防御作用,也具有支持作用。它调控肠道中的微生物,帮助清除大脑、心脏、肝脏、眼睛及其他组织中的细胞副产物,参与修复,并持续衡量各种分子信号是否仍处于可接受范围内。

- 人体大约含有 \(10^{11}\) 个 T 细胞,它们被描述为携带不同受体的独立“自由行动者”。每个 T 细胞都会对肽及其他分子信号进行采样,并能在某些信号似乎超出正常范围时作出反应。免疫细胞也会彼此沟通,形成类似突触的接触,并组装成局部多细胞簇,类似小型信息处理网络。

- HIV 通过感染并耗竭 CD4 T 细胞,揭示了免疫系统作用范围之广。在艾滋病流行期间,患者变得容易受到通常无害的环境微生物、卡波西肉瘤等机会性癌症以及神经系统问题的侵袭。这帮助确立了一个认识:免疫能力的重要性远远超出传统意义上的感染。

- 人类是生物生态系统。覆盖皮肤并栖居于肠道中的微生物提供了额外的基因和代谢能力,而仅靠人类大约 20,000 个基因并不能提供这些能力。肠道微生物帮助处理营养物质,包括参与胆汁酸和动物脂肪消化的成分;有些人群还获得了有助于处理海藻的微生物功能。

- 早期免疫发育既涉及克制,也涉及学习。Krummel 表示,在出生后大约最初六个月内,免疫系统相对难以训练,可能是因为快速的发育变化若非如此就可能被误认为外来物质。此后,儿童经常生病,是因为大多数病原体对他们来说都是新的,不过其旺盛的免疫系统通常能迅速清除感染。麻疹、腮腺炎和风疹等危险感染,是儿童应当接种疫苗而不是依赖自然暴露的理由。

- 衰老会减少免疫细胞的生成并削弱其功能,同时身体本身也会变得越来越异质。DNA 复制错误、环境暴露和克隆选择,会使老年组织成为遗传镶嵌体,而不再是由完全相同的细胞组成。Krummel 引用了一个估计:每个皮肤细胞每天会出现 10,000–30,000 个突变;但他同时强调,基因组极其庞大,确切数字不如差异的累积重要。

- 这种镶嵌性使“自我”与“非我”的区分更加复杂。Krummel 将其比作战时潜艇利用声音特征手册区分己方与敌方发动机:随着身体积累越来越多的变体,其“自我”参照手册会变得拥挤,使恶性细胞或受感染细胞在背景噪声中不那么显眼。

- 免疫系统很可能会在许多异常细胞形成肿瘤之前将其清除。Krummel 提出,一些在中年出现的小块白色皮肤斑,可能代表免疫细胞清除了潜在癌前黑色素细胞的位置。然而,组织修复会选择那些分裂效率高的细胞;这种有助于闭合伤口的生长优势,如果被推得太远,也可能支持癌症和转移。

- 癌症通常发展缓慢。急性病毒感染会导致外来分子和组织损伤迅速增加,而肿瘤可能增长得足够缓慢,以至于免疫系统逐渐将其容纳为身体正常状态的一部分。癌症免疫疗法可以通过改变激活阈值或阻断抑制性通路,克服其中一部分耐受。

- 免疫系统并不总是追求彻底灭菌。许多病毒会留下物质,或以潜伏状态持续存在。杀死所有受感染细胞可能比容忍休眠病毒更糟,尤其是在涉及神经元等不可替代细胞时。与疱疹相关的疼痛和损伤,可能有一部分反映的是免疫系统对携带病毒的神经组织发起攻击,而不完全是病毒本身造成的损伤。

- 胸腺产生并教育 T 细胞。源自骨髓的前体细胞进入胸腺,生成具有极其多样受体的细胞,并接受筛选,以防止对自身具有强反应性的细胞离开胸腺后攻击器官。T 细胞中的“T”最初指的就是胸腺。

- Krummel 强调了 Jacques Miller 的工作:医生观察到,一些儿童在心脏手术中被切除了出乎意料地巨大的胸腺后发生严重感染;此后,Miller 切除了新生小鼠的胸腺。这些动物出现了极强的感染易感性,有时还会形成肿瘤,这帮助证明了胸腺的核心作用。

- 胸腺在婴儿期和儿童期体积很大、产能很高,随后逐渐退化,并随着年龄增长变得非常小。恢复胸腺输出,未来或许能够为癌症或与衰老相关的免疫衰退提供新的 T 细胞;但储存胸腺组织需要侵入性手术,而且目前没有已经确立的长寿用途。最终,构建胸腺上皮支架可能比储存一块胸腺组织更有用。

- 睡眠似乎提供了一个免疫与代谢维护期。睡眠期间,许多免疫细胞返回骨髓,而中性粒细胞进入组织,并可能沉积胶原蛋白。免疫活动会重新组织或变得更安静,这可能使修复和能量代谢副产物的清除得以进行。睡眠也支持淋巴引流;Huberman 将睡眠不足后的眼下肿胀和双眼无神,部分归因于淋巴清除受损。

- 一两个晚上睡眠不佳如何导致感染易感性上升,其完整机制仍未确定。Krummel 表示,有多个研究团队提出了彼此竞争的解释,不过夜间免疫细胞迁移得到了相对充分的支持。因此,应当把睡眠视为重要因素,但不应假装某一条通路就能完整解释睡眠对免疫系统的影响。

- 免疫系统的解剖结构既包含迁移,也包含驻留。有些细胞在血液、组织、淋巴系统和淋巴结之间循环,而常驻细胞群则留在特定器官内,提供局部防御或支持。移植组织必须获得血流、生长因子、淋巴引流,有时还需要神经输入,同时也必须避免免疫排斥。

- 组织情境和空间梯度非常重要。在伤口愈合过程中,位于伤口边缘的细胞和距离较远的细胞接收不同信号,并执行不同任务。即使一种肽、工程化细胞或药物在某个位置或阶段具有有益作用,如果同时施用于全身各处,也可能破坏这种组织结构。

- 基因工程细胞可能在免疫学上变成外来物,因为病毒载体、质粒或新表达的蛋白质会赋予它们新的分子身份。即使起始细胞来自患者本人,这仍然是组织工程和移植面临的障碍。

- 脐带血含有造血干细胞,而且相对容易采集,因为脐带原本会被丢弃。原则上,这类细胞能够在放射治疗或骨髓癌治疗后恢复造血功能。Krummel 倾向于在经济条件允许时进行储存,但承认他不知道商业化私人储存是否有明确证据证明曾挽救过某个原本会死亡的人。因此,他强烈暗示储存的脐带细胞“会治愈”儿童白血病,其确信程度超过了他本人所引用证据的支持范围。

- 使用山中因子制成的诱导多能干细胞和类器官,最终可能支持替代器官的生成或个性化药物测试。Krummel 认为,更迫切的问题是实验室分化是否真正再现了一个具备功能的器官,而不只是原始成纤维细胞是否携带突变。时间表仍不可预测:加利福尼亚州的再生医学计划带来了大量知识,但近期疗法比预期更少。

- CAR T 细胞及其他工程化 T 细胞方法体现了这种不确定性。它们可以被设计为识别肿瘤,但实体瘤通常会使其失去功能或陷入耗竭。尽管多年来人们一直很乐观,许多应用仍反复未能消除患者体内的肿瘤。

- Krummel 在 James Allison 实验室中的研究生工作,帮助开启了免疫检查点癌症疗法。在证明阻断一种 T 细胞分子会增强激活后,他将该抗体注射给荷瘤小鼠,并观察到肿瘤消退。那项由好奇心驱动的实验推动了后来令 Allison 获得诺贝尔奖的工作。同样的免疫放大,在模型中改善了疫苗接种效果,却会加重多发性硬化症,同时攻击肿瘤——这表明“更强的免疫”并非普遍更好。

- 突破往往源于与最终应用无关的基础研究。CRISPR 源自对细菌防御的研究;X 射线源自物理学;与 GLP 相关的肥胖症药物,部分可追溯到对希拉毒蜥的研究;包括 Elly Tanaka 对蝾螈所做工作在内的再生研究,即使转化过程缓慢,也可能为未来疗法提供启示。Krummel 认为,许多失败或看似琐碎的实验都是必要的,因为真正的新发现并不存在于现有知识之中。

- 机器学习可以绘制基因、免疫细胞、成纤维细胞、上皮细胞及其他组织特征之间的关系,帮助研究人员提出实验。目前的 AI 最擅长重组现有语料,而发现往往涉及尚未存在于该语料中的事物。昂贵的生物学实验和人类判断仍然必不可少。

- Krummel 将反复出现的多细胞组织构型描述为“原型”,类似于不同团队执行不同战术。改变疾病可能需要一连串推动:拆解肿瘤的伤口愈合环境,改变特定细胞群,然后才教会免疫系统杀死肿瘤。单一干预可能失败,因为生物系统具有韧性,并会进行补偿。

- 大脑状态可以影响特定器官的免疫状态。Krummel 引用了一个与 Roy Slab 有关的以色列研究团队的工作:研究人员在小鼠体内诱发肠道炎症,标记患病期间活跃的岛叶皮层神经元,等待小鼠康复,随后重新激活这些神经元。之后,免疫细胞开始在肠道中重新聚集,形成类似原始炎症状态的模式,不过强度较低。

- 这表明,大脑可能会在储存情境记忆的同时,储存身体免疫状态的某些方面。回忆某种情境、气味或情绪状态,可能会通过包括迷走神经在内的自主神经通路,部分恢复相关的生理状态。Krummel 和纽约大学医师科学家 Dan Littman 讨论了冥想是否可能成为一种推动这些网络转向较低炎症状态的方法,但 Krummel 强调,这一想法具有合理性且正在发展中,并不是已经确立的临床方案。

- 免疫分子可以改变行为。Huberman 引用了一些实验:给原本未感染的小鼠施用一种与感染相关的炎症信号后,会引起社会退缩;他还指出,大脑中存在免疫信号受体。母体免疫激活也被用于实验中,使小鼠后代产生类似自闭症的发育变化,这证明炎症可以影响发育中的神经系统。

- 这种动物模型并不能证明疫苗会导致自闭症。Krummel 列出了多种其他可能性:母体感染、发热、易感情境下与疫苗相关的炎症,或者仅仅是时间上的巧合,因为发育差异往往在接种疫苗的年龄阶段开始变得明显。他的立场是,神经—免疫效应在生物学上是可能的,但因果主张需要好得多的人体数据。

- 关于疫苗,Krummel 区分了总体收益与接种时间、组合和沟通方面的问题。他让自己的孩子接种了疫苗,并认为风险—收益平衡明显有利,尤其考虑到天花、麻疹、腮腺炎及类似疾病的严重后果。他认为麻疹重新流行令人担忧。

- 不过,他也同意,最初的疫苗研究可能并未测试过所有现代疫苗组合或接种间隔安排。他曾因为一个女儿身体不适,将她的疫苗接种推迟约一个月;他还指出,略有不同的接种时间表仍然可以保护动物。标准接种时间表能够提高依从性、统计置信度和便利性,但并不一定是唯一有效的时间表。

- Krummel 将带状疱疹疫苗描述为使用了大量佐剂,而且曾使他本人在一段时间内无法正常活动;同时他表示,不知道这种强度是否必要。他支持对不同疫苗组合和接种时间表进行透明的比较研究,而不是驳斥合理问题或放弃接种疫苗。

- 疫苗犹豫涉及科学、个人自主权、历史、信任和制度激励。父母如果感觉孩子在接种疫苗后发生了剧烈变化,可能会经历悲伤、内疚和愤怒,因为他们选择这项干预原本是为了帮助孩子。仅仅存在时间上的关联并不能证明因果关系,但轻蔑或强制性的沟通会加剧不信任。

- 科学机构在社会层面并非中立。塔斯基吉研究仍在影响美国黑人群体的不信任。Krummel 认为,科学家必须以普通人的方式沟通,以易懂的语言解释不确定性,并承认制度历史,而不是期待仅凭资历就能赢得信任。

- 制药公司生产了挽救生命的药物,Krummel 表示,大多数科学家和行业研究人员真诚地希望帮助他人。然而,公司激励机制仍可能偏离患者利益。他以黑色素瘤的免疫检查点疗法为例:如果一种药物能治愈大约 50% 的患者,但没有检测方法能够识别哪些人会响应,那么所有人都会接受该药;公司可能没有多大商业动力去开发一种会使其市场规模减半的检测方法。

- 使用未经批准、从网上购买的肽或其他物质进行自我实验具有风险,因为身体干预可能造成不可逆伤害,剂量和纯度可能未知,而轶事无法确立因果关系。Krummel 并不一概反对实验,但他希望看到临床前和临床证据、系统性数据收集以及针对具体情境的评估。

- 自身免疫性疾病可以被理解为免疫程序攻击了错误靶点,或在错误组织中启动。有些疾病具有遗传成分:Krummel 描述了与家族性狼疮有关的抑制性 B 细胞受体缺陷,这种缺陷会导致产生过多自身抗体。

- 哮喘并不是一种统一的疾病,而是一种共同症状——呼吸困难——其背后可能存在七八种免疫构型。不同病例可能由花粉、氯、寒冷、嗜酸性粒细胞、中性粒细胞或其他通路驱动,这解释了为什么一种吸入剂或免疫治疗对某个人有效,却对另一个人无效。

- 银屑病、狼疮、炎症性肠病及其他自身免疫性疾病,也包含不同的免疫亚型。TNF 阻断药物可以显著帮助一些炎症性肠病患者,但临床医生无法可靠预测谁会响应,而且疗效可能随时间消失,导致依次进行“打地鼠式”治疗。

- 一些与疾病相关的免疫特征,可能在另一种环境中带来好处。Huberman 提出,轻度银屑病或较高的 IL-17 相关活性,可能是以皮肤炎症换取更强的病原体抵抗力。Krummel 支持这样一种总体进化原则:群体多样性会保存那些在不同条件下可能变得有用的特征。

- Krummel 用细菌说明了这一点:在葡萄糖中生长最快的细胞,转移到半乳糖中后可能失败,而先前生长缓慢的“失败者”则成为赢家。他还提到了镰状细胞变异带来的疟疾保护作用,不过这段对话错误地将镰状细胞病与血友病混为一谈。

- 个体的营养需求可能存在很大差异,因为代谢酶会因遗传而异。监管机构制定的摄入量数值是群体平均值;Krummel 推测,有些人对某种营养素的需求可能是平均水平的数倍,或低至其几分之一。这并不能证明不加区分地补充营养素是合理的;Huberman 将这种做法描述为漫无目标。

实用要点

- 保护规律睡眠。即使完整机制尚未解决,睡眠仍支持免疫细胞迁移、组织修复、淋巴清除和代谢清理。

- 将健康视为一个协调系统:睡眠、运动、营养、昼夜节律光照、压力管理、亲密关系和社会联系,共同构成药物和免疫干预发挥作用的背景。“通过化学获得更好的生活”仍然需要把生活本身过得更好。

- 不要认为更强的免疫激活总是可取。同样的放大作用,可以改善感染或肿瘤控制,同时也可能加重自身免疫、炎症或组织损伤。

- 与合格的临床医生讨论疫苗接种时间或暂时推迟接种的问题,尤其是在儿童正处于急性不适时。不要因为接种安排存在不确定性,就推断疫苗不能针对严重疾病提供强有力保护。

- 谨慎对待未经批准的胸腺肽、网上来源的化合物、植入组织和其他自我实验。相关的剂量、纯度、位置、时间、免疫相容性和长期风险可能未知。

- 如果采集费用和持续储存费用可以接受,储存脐带血可能是合理的;但家庭应要求服务商提供有记录的临床效用,而不是依赖假设性的未来治愈方案。

- 将补充剂和免疫治疗视为针对个体的假设,而不是普适解决方案。个人状况的改善可能来自干预,也可能来自偶然、预期效应、同时发生的其他变化或自然波动。

- 对于哮喘、银屑病、炎症性肠病、狼疮、癌症或其他免疫介导疾病,应预期存在生物学亚型和不同的治疗响应。应与临床医生合作,重新评估疗法,而不是因为一种药物失败就认为整个治疗类别都无效。

- 冥想等心理练习可能影响自主神经和免疫状态,但由记忆触发的免疫控制仍是一个新兴研究领域。它应当作为既有医疗护理的补充,而不是替代。

- 当证据稀少时,应询问什么实验能够区分彼此竞争的解释。把合理机制、相关性、动物研究结果、轶事和已经得到证明的人体结果区分开来。

注意事项与局限

- 讨论中的许多内容属于概念性观点,依据的是动物研究、新兴空间生物学或专家解读,而不是已经完成的人体临床试验。

- Krummel 反复区分已经确立的事实与他认为合理的观点。睡眠不足与感染之间的联系、有意识地回忆与有益免疫状态之间的联系、恢复胸腺功能与长寿之间的联系,以及储存干细胞与未来治愈之间的联系,其机制仍不完整或存在不确定性。

- 小鼠母体免疫激活模型证明了炎症能够改变神经发育;它们并不能证明常规疫苗接种会导致人类自闭症。

- 疫苗不良事件可能发生,但轶事和时间上的接近无法确立因果关系。反过来,也不应利用不确定性来驳斥真诚报告,或阻碍更好的安全性与接种安排研究。

- 恢复或放大免疫功能存在权衡。新的 T 细胞可能攻击肿瘤,但也可能攻击自身;免疫检查点疗法可以治愈某些癌症,但也可能伤害正常组织;阻断炎症通路可以缓解自身免疫,同时可能削弱对感染的防御。

- 组织工程受血管供应、淋巴引流、生长信号、神经环境、空间梯度和免疫耐受的限制。在小鼠体内成功生长肿瘤或组织碎片,并不能确立安全的人体移植方案。

- 对再生医学、类器官、CAR T 细胞、肽和长寿的预测尤其容易受到炒作影响。科学进步可能突然到来,但研究人员和消费者都无法知道,这些进展能否及时惠及某个特定的人。

- 有些数字和医学陈述是在对话中提出的,不应视为临床指导。访谈文字稿将镰状细胞病与血友病联系起来是错误的;其关于私人储存的脐带血能够治愈儿童白血病的说法,也比讨论中证据所能支持的结论更加绝对。

- 监管机构提出的营养素建议量是平均值,但关于个体可能需要某一给定摄入量的五倍或五分之一的说法,只是示例,并不是剂量方案。

- 科学论文经常强调研究潜在的重要性或未来的可扩展性,以吸引关注。“可能与……有关”并不等同于“已被证明会导致或治愈……”。

- 制度、商业和政治激励可以塑造研究与沟通,但这并不能成为全盘拒绝科学、疫苗、药物或医学的理由。Krummel 更倾向的回应是提供更透明的数据、设计更好的实验、承认激励机制的存在,并进行细致入微的公众沟通。

Full transcript

a famous scientist in the 1970s, drew this parallel in wartime and said in World War II, submarines had two sets of books. One of them was a book that gave them the sound profile of all the US submarines, and so they could listen to the whir of the engines, and if they heard a whir of the engine that had the certain cycle of a General Motors engine, they wouldn't fire. So that's the sort of like self, I know what self is. And then they had another book that was the engine sounds of the known diesel engines of whatever engines of the German submarines.

And if they heard that, then they absolutely would fire. And that's a self versus non-self discrimination problem, just like the immune system has to do. But when I bring you with it, aging is this concept that as you get weirder and different, your body is getting more complex, then those books start to have every possible, possibly, every possible permutation of every biomolecule could be made by your body at that point. And then a virus doesn't necessarily have anything unique about it. the Huberman Lab podcast, where we discuss science and science-based tools for everyday life. I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. My guest today is Dr. Max Kromel, a professor and leading expert in immunology and cancer biology at the University of California, San Francisco. Today, we discuss your immune system, how it works, what it needs to function at its best, and how things like aging, vaccines, sleep and even your thoughts and emotions shape immune function. For instance, most everybody knows that being sleep deprived makes you more prone to getting sick. But why? Meaning mechanistically why? Well, it turns out there's a specific set of cells that need to migrate in a particular way during sleep. And we talk about how you can reinforce that process in ways other than sleep.

We also discuss incredible findings that certain brain states and memories can be associated with within immune system status you had when those memories formed. And evidence that just recalling those memories, thinking about where you were, what you were feeling at those times when the memories formed can activate your immune system in the same way, which is remarkable. We also have a very candid discussion about vaccines and medications more broadly. You'll notice that Dr. Cromwell is incredibly balanced throughout today's conversation. And yet he's also willing to state his views very clearly. So it provides a very rich discussion about vaccines and all the rest.

Indeed, thanks to Max's incredible breadth of understanding of immunology and much more, and his ability to break down complex topics and make them accessible, plus his genuine care for public education and science, today's is a truly special and important episode to educate and inform you in actionable ways. I should also mention that Dr. Cromwell has an incredible zero cost sub-stack. It's called the Immune Beyond. You can access it by going to theimmunebeyond, all one word.substack.com. And there he teaches about science and more. Again, it's awesome, it's free. So definitely check it out. Before we begin, I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford.

It is, however, part of my desire and effort to bring zero cost to consumer information about science and science-related tools to the general public. In keeping with that theme, today's episode does include sponsors. And now for my discussion with Dr. Max Krummel. Dr. Max Krummel, welcome. Thanks. Most everybody, including me, has heard of this thing we call the immune system. And most people just think, okay, this is the thing that when I'm rested, it keeps me from getting sick. And when I'm not as well rested, I tend to get more sick. And there are these airborne things and we can get sick.

And there's like, funguses and viruses. And I think that's probably what most people understand. And they probably also understand that there are like cells and T cells and B cells. But if we want to think about a little bit of the history of our understanding of the immune system and what we understand now, maybe you could orient us because in reading your work prior to this discussion, I'm realizing that this is a very recent field and also there's still a lot that we do not understand. When I started in immunology, sort of 30 years ago, I was rotating in labs at Berkeley.

I think you were at Berkeley as well. And one of the transcription factor biologists, mentor said, why do you wanna work in immunology? It's not really a field, and so the time was kind of true. Everything was about DNA, cloning. It's obviously still a lot about molecular biology, what we do, but at the time it was pretty simple. We thought of the immune system as something that, on the one hand, it had to come into play when you saw a virus or something foreign, and otherwise it generally had to be quiet and kind of leave you alone. I think cancer immunotherapy changed that a lot.

That gave us the idea that you could tune its reactivity so that you could get to the point where if you gave an immunotherapy, what it was actually doing was raising the threshold of when a T-cell would activate and allowing T-cells that might be just letting the tumor get by, they'd be able to go after that tumor and kill it. I think that changed the spectrum of a certain degree where we suddenly thought, okay, this isn't just a foreign versus self thing because a tumor is not exactly self, but it's also not foreign. It was once you. It's a cell that's evolved.

So I think tumor immunology really changed our perspective on that to the point where we now think of it as a tunable system. But then I think a lot has happened in the last 20 years. There's been a lot of excitement about cancer immunotherapy because we're curing people with cancer, which really wasn't done before. You're now in the space where the immune system is showing all these other roles. You know it in the nervous system, the brain, there's microglia that do various functions, cleaning up, et cetera. But it's in your gut. It's allowing microbes to live in you, but it's titrating them.

It's keeping them there in the kind of like the right quantity. So it's kind of guarding yourself. It's you know, it sits in your liver regulating how much you metabolize. There's a collection of cells there. It's in your heart. It's you know, regulating cardiomyocyte function. Those are the muscle cells of your heart. They have to be cleaned up from time to time. So there's a set of immune cells that will help get rid of their byproducts in the heart. So, it has all these additional functions that kind of before we're lost in the just the foreign battle against the foreign.

And now we have this kind of perspective of this system that measures us all the time. It measures everything about us and it exists in some ways, I think is to help us be who we are. And hopefully that's you as a healthy person. In chronic disease, unfortunately, it can be part of the problem where it becomes part of the things that's letting the chronic thing, whether that's a tumor or kidney disease or what have you, it can actually help perpetuate it because in some ways it's trying its best, but it's applying the wrong program to the wrong situation. So, yeah, it's changed a ton. And I'll give you another little funny story, which is that when I first came into immunology, and we had this story like a mentor who says, You know, this isn't really a field.

The year was ... I came into the field in 1989, and that's right at the peak of AIDS. AIDS was like as a biologist was really interesting because the HIV virus infects T-cells, so your body is filled with 10 to 11th or so T-cells, like a ton of different kinds of T-cells. You have a subset of T-cells that are called CD4 T-cells, kind of a flavor of T-cells, and the virus gets rid of those. So HIV virus will infect the CD4T cells, and then you end up with not having them. And the manifestations of AIDS, for those that weren't around or in, was just a ton of different opportunistic infections.

So soil bacteria that you and I fight off without even thinking about it would kill people. But so too would you see, you saw people with carboxysocoma, you saw opportunistic cancers emerging. And you just saw all these kind of manifestations of where the immune system was important, dementias in people with HIV as well. You know, it was early accent at the time on how many different things the immune system might be important for. So regardless of whether, you know, it was a field or not, it was clearly important. And it was all these things we didn't know about it that like fueled the discoveries that have led to where we are right now.

And some of those, you know, I think it's worth pointing out, were just these curiosity questions like, what are these cells? Like they were hard to study in the beginning. They don't live, it's sometimes hard to keep cells out of a human body alive. So there's issues about how do you keep these things alive in the very first place and then what kinds of things trigger them to do stuff and make reagents to test those ideas you might have about what they might do. It was a long haul, I think, to get ourselves together where we now have a pretty good understanding of all the molecules and cell types and the behaviors that they can engage in.

And it just gets more complex and more like rich as we understand that they're basically every single T cell in your body is like a free agent and they're part of a sensory system. Each one can measure the concentration of a set of biomolecules, proteins, in the form of peptides, they can measure that. And each one then can say that's out of range or that's in range. So it's like you have like 10 to the 11th little sensors going around you curating you, making sure you're the right thing. And if they see something that's out of range, they can do something about it.

The whole thing is magnificent. It is magnificent. Do you mind if we take a developmental perspective on this for a second, and then I have a basic health question. The developmental perspective is, I think most of us either remember or have observed that when humans are young, they get sick a lot more. Presumably that's because their immune system isn't as well developed. But kids tend to get sick and then get over being sick pretty quickly. Maybe you could describe what's going on there. And it also is the case that, you know, as we get older, much older in fact, last quarter of life, let's say, people tend to get sick more.

What's going on in terms of immune system function? Or is there something more broadly happening at level of just kind of energetics mitochondrial function? I'm very curious about this. If I can take a step even further back, I will ask you a question of like, who are you? And I don't mean that like in a personal sense, but I can talk about that too if you want. But the more the question is like, at some point, where does your body end and where does the world outside start? And one of the things that you start to realize if you look in a microscope is that we're covered with microbes all over our surface, we're covered with microbes all the way in our gut.

In fact, we can't, you can't digest, you've probably heard this before, but you can't digest animal fats if it weren't for the bugs, the bacteria in your gut. They make some of the key components of bile acids that allow you to digest animal fats. So you need this system that's around you. So you aren't just the cell, like if you learn biology, you've got the, again, we're going to go way back. There's the egg and the sperm and the fertilize and now you've got this cell that starts to divide and gives rise to every other cell in your body. So you might say that your body is just that collection of cells.

But in fact, it's absorbed a lot of viruses and bacteria from our environment. And to go into that really briefly, that's really important because we only have 20,000 genes in our genome. So there's only so much in a given life that we can do with those genes. And so by absorbing all kinds of other species onto us, we get their genomes. So like you said, like I was saying, the bacteria in your gut can now help you absorb nutrients that you wouldn't otherwise. If you eat sushi, you know, you've heard this probably, right? get bacteria in your gut that can help you absorb the seaweed, nutrients from seaweed.

So taking this into your question, when you're first born, you've never really seen anything. And so two things are worth pointing out at the early phase of life. One of them is for the first six months or so, your immune system is pretty poor at being trained on things. And it's presumably, we presume that for those six months, that's because your body's developing so fast that if you were to have a super active immune system, you might actually find yourself attacking yourself. You might think that you're foreign because some genes turn on during development and then all of a sudden your immune system is like, oh, I see something different and now I need to react.

So that's well known and that's one of the reasons why some childhood vaccinations, they're really important to protect kids over life, why they aren't given until you're six months or older. But I think to your point, one of the things that's happening with kids is that then as they go until they're 10 and you're talking about they get sick a lot, they just haven't seen a lot of these bugs before. So they don't have an immune system that knows what flu is, because the body's never... That body, the kid's body has never seen flu before. So every single virus and pathogen that hits it is going to elicit some amount of illness.

But then they have a very strong immune system. It reacts and gets rid of that, with the exception of the ones that are... Those certain viruses and bacteria, mumps, measles, rubella, that are lethal, and that's That's why we immunize, as we say. Those are things that your immune system, if they get too much of those, kids will die. It's better to protect them with a vaccine. That's the front end. The front end has this initial immunosuppression, then just exposure to all these things that are in our environment and you and I take on as part of our genomes, but we have to reach a detente with some of them.

We have to get to the point where the immune system can fire back when they show up, if They're bad and allow them to live in us if they're good with us. I think that's what's happening a lot in those first years of life. You can see that both in the form of kids getting sick a lot, but you'll also see that their guts develop way diverse microbiome. They allow a whole bunch of things that come in from the outside and are acceptable and are quite good for you. That's the front end. In the back end of life, it's a little bit more complicated, but I'll tell you two things that I think are important.

On the one hand is the idea that is the fact that a lot of your cells in general become less functional, including immune cells, and you get less cells produced, and that might just be because we were never selected as organisms to live as long as we do right now. That's one idea of aging, right? Yeah. Did you know that? That we just were supposed to be dead by 70? Well, no, but we do know that we can reproduce and pass on our genes successfully already when we're 16. So the selective pressure to pass on your genes, if you imagine that's how genetic evolution happens is that you pass on your genes as being successful.

You can already do that at 16, and anything after that is just cream on the crop. But at some point, maybe there's no selection. So we don't know that, but it's a reasonable hypothesis to say there wasn't any real selective pressure for passing on genes that do anything past when you're actually having kids. The psychologists would tell us that the wisdom of people, 60, 70, 80 and beyond is useful for groups of humans that live in villages of a hundred or so people because they can give information to younger people that is on the periodicity of like every five to 10 years, maybe every 30 years, but that's a just so story, right?

It's a nice just so story. I like it too and I think that geneticists will refer That's like the grandfather effect where genes may be selected for, and maybe they're mostly about genes that make us social for the elderly, that do ... They're going to have effects on the fitness of their grandchildren, which is their genes. And so, I think there's something to be said for that in conceptual space. I don't know if I can prove it to you that that's- It's a tough experiment to do. It's a really tough experiment to have two villages where the grandparents are eliminated You're kept both non-ethical and also non-ethical.

But we're talking about the aging immune system, and I think there's two things that, again, come to this question that I was asking, like, who are you? And I was saying, okay, well, in aging, you have this issue that the immune system is tapering and it's efficacy. It's many of the cells that you've been holding your whole life start to, literally, they die off. But there's another thing, which is I think a lot of people don't realize when you say, when the basic biology would say that sperm, like fertilized at the egg, so you've got your mom's genes and your dad's genes. You've got 23 chromosomes from your mom, 23 chromosomes from your dad. When you're first born, every cell is a clone. It has exactly the same information.

But DNA replication and DNA fidelity isn't perfect. They say that on your skin, the cells of your skin may have somewhere between 10 and 30,000 mutations per cell per day, just from basic sonic exposure. That's higher than some of the other organs. But the basic The idea is that your DNA is susceptible to UV radiation, that's one of the reasons we put on sunscreen. But what it practically means, no matter what number you put in there, whether it's 10,000 mutations per day or ... Remember, the genomes are huge, so 10,000 mutations out of terabytes of information still is only a certain number, but do that over years.

And the main thing that that means is that every cell in your body is no longer identical than the one next to it, because this one got different mutations on day one, this one and got some mutations on day two, and slowly but surely, you are becoming like a mosaic. And I say mosaic because like the tile that you see in Morocco, very intricate designs, because if you actually start to look into tissue, you'll find that certain clones, certain mutations do make certain cells more fit, and they're the ones that if you scratch yourself in a cell, some new cell has to form, they might be the fittest to fill that void.

And one of the other clones over here that got a different mutation may not be fit to fill that clone. So you end up with this pastiche of who you are. So now, again, I ask you, like, who are you now? So if I want to defend against something that looks different, what if everything looks different? What if every cell is different from every other cell? It's, okay, you want another analogy? I would like another analogy. The only exception that I can think of to this, and that could be wrong, is that our neurons, our central nervous system neurons, brain and spinal cord, most all of them are the same ones that we were born with.

Same cells, but they're... Same cells, but they're... So you're saying mutations are constantly accruing in the neurons as well. In the DNA. So there's this... It is fascinating, by the way, that neurons live that long and, you know, hair cells, they say that the proteins in our hair cells of our ear are the same exact molecules, atoms, as we have when we were born. So there's some cells that are long... But in their nuclei, the DNA that's encoding who they are, who those cells are, is subject to mutation ongoing, and it depends on how deep they are. We tend to think that one of the reasons that immune stem cells live in our bone marrow, our long bones are hollow, and in there is the source of the immune system's revitalization.

It's the stem cells that make more white blood cells. We'd like to think that they live in there because it protects them from a reation. They hang out, and stem cells are ... The bone actually serves not only a structural purpose in our body, but it's a cavity in which things can live. Keep it away from solar radiation, keep it away from chemical cues in the environment that can mutate. Exactly. Sequestor your stem cells. Don't burn them. Yeah. That kind of thing. Yeah. Likewise, the neurons in the inside of the skull and the spinal cord are protected. They're protected. Yeah.

And that's interesting. Yeah. Yeah. I would like to take a quick break and acknowledge one of our sponsors, Juve. Juve makes medical grade red light therapy devices. Now there's one thing that I have consistently emphasized on this podcast is the incredible impact that light can have on our biology and our health. Now in addition to sunlight, which I've talked about a lot on this podcast, red light, near infrared and infrared light have been specifically shown to have positive effects on improving numerous aspects of cellular and organ health. These include faster muscle recovery, improved skin health, wound healing, improvements in acne, reduce pain and inflammation, improve mitochondrial function, and even improvements in vision.

Nowadays, there are a lot of red light devices out there, but what sets Juve lights apart and why they're my preferred red light therapy device is that they use clinically proven wavelengths, meaning they use the specific wavelengths of red light, near infrared, and infrared light in combination to trigger the optimal cellular adaptations. Personally, I use the Juve whole body panel about three to four times a week, usually for about 10 to 20 minutes per session, and I use the Juve handheld light both at home and when I travel. If you would like to try Juve, they're offering up to $400 off select products for listeners of this podcast.

To learn more, visit Juve, spelled J-O-O-V-V dot com slash Huberman. Again, that's J-O-O-V-V dot com slash Huberman. Today's episode is also brought to us by 8Sleep. 8Sleep makes smart mattress covers with cooling, heating, and sleep tracking capacity. One of the best ways to ensure you get a great night's sleep is to make sure that the temperature of your sleeping environment is correct. And that's because in order to fall asleep and stay deeply asleep, your body temperature actually has to drop by about one to three degrees. And in order to wake up feeling refreshed and energized, your body temperature actually has to increase by about one to three degrees.

Eight sleep automatically regulates the temperature of your bed throughout the night according to your unique needs. I've been sleeping on an eight sleep mattress cover for nearly five years now, and it has completely transformed and improved the quality of my sleep. The latest 8 Sleep model is the Pod 5. This is what I'm now sleeping on and I absolutely love it. It has so many incredible features. For instance, the Pod 5 has a feature called Autopilot, which is an AI engine that learns your sleep patterns and then adjusts the temperature of your sleeping environment across different sleep stages. It'll even elevate your head if you're snoring and it makes other shifts to optimize your sleep. If you'd like to try 8 Sleep, go to 8sleep.com slash Huberman to get up to $350 dollars off the new Pod 5.

8Sleep ships to many countries worldwide, including Mexico and the UAE. Again, that's 8sleep.com slash Huberman to save up to $350. Sometimes I tend to think the immune system, you want to defend it like you want to defend a nation. And you want to defend it from outsiders. And I've just told you a story that if you want to take a political statement from its pro-immigration because all these bacteria that live on us are actually bringing us goods. And they do a lot of work. We just lost half the audience. I'm sorry. I'm just kidding. We're a bipartisan audience, so I'm totally joking.

Take it how you want, but by analogy, it's the argument for why certain influx of, in this case, organisms onto us create a more robust person than we were before. But I want to give you this story that a famous scientist in the 1970s drew this parallel in wartime and said in World War II, submarines would be underneath the ocean and they'd be traveling around, and they would ... If they heard another submarine, they would scuttle the missiles, the torpedoes, because that could be the enemy, and the enemy could fire at them. They had two sets of books that they used.

One of them was a book that gave them the sound profile of all ... Let's say it's a US, of all the US submarines. They could listen to the whir of the engines, and if they heard a whir of the engine and had this certain cycle of a general motor's engine, they wouldn't fire. So that's the sort of like self, I know what self is. And then they had another book that was the engine sounds of the known diesel engines of whatever engines of the German submarines. And if they heard that, then they absolutely would fire. And that's a self versus non-self discrimination problem, just like the immune system has to do.

But what I bring you with aging is this concept that as you get weirder and different, your your body is getting more complex, then those books start to have every possible, possibly, every possible permutation of every biomolecule could be made by your body at that point. And then a virus doesn't necessarily have anything unique about it. A virus is also going to make proteins, and that's your immune system can see the viral proteins and say, oh, a new thing has come in and that's out of range, and now I need to mount that T-cell response against this. I need to bring in the troops.

But with aging, we have this kind of us diverging problem so that this system that's supposed to sense us has a lot of cosmic background, has a lot of noise in it. And so I think that's one of the reasons why we also have issue when we're aging. And I think it's also one of the reasons why cancer is more prevalent in later life. I mean, there's two parts of that. One is, of course, you've accumulated mutations in your cells that could be cancerous. But also, the immune system has been seeing those and all the various different accumulations of them and ones like them over these years to the point where the weird doesn't look that weird anymore.

Something like a cancer that is different than you. It's not that much different than another cell over here that's gone, and it's just happily making skin and isn't cancerous, but it's got some differences. What about the argument that there's so much cellular turnover that the cells that accumulate these mutations are being eliminated? You're saying because they're clonal, they're producing different ... They become different. They produce cells that are also different. Then they die. Yeah. Is that the way it works? Yeah. I think you are bringing some hip that's also true, which is that all the time I think the immune system is defending us against mutations.

One example that everybody sees when they get to be about 40 or 50 is little of these white spots in your skin. We think that those are places where the immune system has sensed a collection of cells that were precancerous, maybe they were even beginning of cancer, and has wiped them out. And so a lot of the origin of cancers in skin is melanin-producing cells, like melanoma is what we call skin cancer. Those melanocytes, that white area, they've been wiped of a whole collection of melanocytes, and that's why it's white instead of as dark as your rest of your skin.

So to that extent, the idea that the immune system is pruning you all the time, it looks It looks like there's pretty good evidence for that. And the question is, when does somebody become dangerous? That's fundamentally a question with cancer and these sorts of things. If you said, I want to actually have the fittest cells in my skin to fill in a gap if I scratch myself. I really have cells that quickly replicate, just like maybe in kids. Kids heal so ridiculously quickly, right? Because they have an abundance of these cells that I think they're wound healing. I mean, there's a group out of Stanford that studies this, but essentially, wound healing young is quite a bit faster and more efficient and there's many levels of that.

There's many levels of that. Yeah. But yeah, remarkably faster. If you're a parent, you've seen this, you cut yourself on the same day as your kid cut yourself and three days later it came and find it on them and like four weeks later you're still like, you know, scatters me. But I was just coming to the point that if you do that and you maybe want that to fill back in because certainly out in the wild, having an open wound is a bad thing. so you'd like to yield quickly. Well, if a mutation has happened that fills that cell in more quickly, that is almost by definition a mutation that's let that cell divide faster.

Well, what is cancer? It's cells that divide faster. So in some sense, all these events in your life where winners win by filling in the space left by cells that die is selecting for cells that get a little out of range with growth, that they may be a little bit better at growing. And then again, the question is like, well, how much better do you want that? You want it to help you, but at some point, you don't want it to basically form a lesion and grow, grow, grow, grow, grow, and go other places and grow, which is called metastasis in cancer, which is how most people die.

To me, the issue of self and non-self is one of the ones that's been with immunology for a very long time, and again, it's way richer than we thought about, I think, in the 1990s or 2000s. And then at the same time, the idea of what you can do with that information is also, I call this kind of the new immunity. used to be like a fuel gauge. You'd say it was low for itself, then it was really high against viruses and it was like a fuel gauge. Now it's really hot. And what we originally thought we were doing with cancer immunotherapy was making it just hotter generally. But now you realize that in between the immune system not caring about something at all and going and releasing all its fury on something are all these other things that can do with the information that gathers in there. And that's why I was saying it can like quarantine bacteria.

It's not going to kill them. It's in that zone. Bacteria, as long as they're in the right zone, there's not too many of them, there's not too few of them. Immune system can actually help them be there. It can produce things that either tighters them out of circulation or keeps them there. All these other settings, like I say, in the heart, in almost any organ, and the immune system is consistently present, and it's consistently measuring you, and the you, again, is this complex you. It's not just what came from the egg, it's the you that's you right now, including all the mutations that you might have accrued, and all the bacteria, and the viruses.

We have a lot of viruses in our bodies that we tend to think that at the end of an illness that we've gone back to our pure state. This may come from religion. We were born pure, and if God had made us correctly, then we would be pure at the end of things. And that would be pure immunity, which would purify us of things. But the more we look, the more we find that every virus leaves a little evidence, a little bit of itself. And then there's the goal for the immune system to kind of quarantine that, to say this, maybe we don't want to kill every one of our cells to get rid of every virus that's infected one of our cells.

We need to leave some of those alive. For example, herpes virus infection infects the nerves, and when people have emergence, they get nerve pain and worse. A lot of that is caused by the immune system reacting to the virus trying to get out and then killing off neurons. So it's immunopathology, the immune system is causing as much of the damage and problem as the viruses. And it's the failure of that detente, and when certain viruses are just sitting in us, we're perfectly fine. You know, we have new viruses sitting around, and as long as they're laying dormant, our immune system can say, okay, I'm going to just hang out here, and if anything bad happens, I'm going to squelch that.

But it's not like we've been purified. You know, that's a reality that's a little bit too bad, but you know, it's also one where you say, again, if the goal of us is to make it to 30, let's say you get an early liver infection of HCV or HPV. If the immune system can just let that be, you're not going to destroy your own liver and you'll live to produce and your genes will get passed on. On the other hand, if you've mounted a massive immune response, you went all the way in the fuel gauge to the right, your immune system can kill you.

It absolutely can. It can kill any cell it wants. So that, again, that idea that the space in between is the one that we actually are starting to understand that it has all these specialized roles that are not always about getting rid of things at all costs. This raises a question for me, and obviously I'm not an immunologist, but it seems like one- You're going to be one by the end of today. I hope so. I like the sound of that, as will the audience. One potentially useful strategy the immune system could have, perhaps, would be rather Other than to decide to launch an attack on a particular cell because it's mutated and different enough to assess how many cells throughout the body or even just get a local average of how many cells have similar mutations or just are different so that if we are indeed born pure in the biological sense, let's just keep it there for today's discussion.

by time we are 32 years old, we are a mosaic of mutations as it appears we are. If the immune system could surveil multiple regions in the body, maybe compare organs or maybe keep it within organ system and say, you know, the number of mutated cells or not pure me cells would be one way to do it more simply perhaps has exceeded a certain threshold measured, I don't know, Like enough receptors have something in them that the cell goes, okay, you know what? I'm gonna fight. In the same way that, you know, soldiers, you know, they might hear a shot whiz by, but then do they necessarily reveal their location and launch an attack?

No, but if it's enough of an attack, they'll fight back. It seems like there should be some way that the immune system could quantify either body-wide or local Oregon or over some period of time could integrate over time. I have to imagine that such a mechanism exists. You're coming from neurobiologists, I know. And so there is that in neurobiology of accommodation, right? I always tell the story of, I went to this little village in France called Epos, if you know the name. Epos is kind of a famous cheese that they make in this town, and it's super stinky. And they make it only in that town, and they make a lot of it in that town.

And so when you drive into that town, it's like somebody has the worst foot odor. It's striking. It really hits you. after being in the town for like an hour, you don't notice it. And that's neuronal accommodation where you're nervous. There's the same kind of thing you're talking about where the sensors in your nose can become, they're like, okay, I've seen it, I've seen it. Now it's not anymore, and so I'm gonna tune that out because then your nose has the potential to smell other dangers or other stuff, right? So that's the nervous system. I think you're exactly right where you're going with this.

And we think this is true, that the immune system is for danger. It's looking for something that you would call like, It's how it's seen the signal over time. So a virus may, let's say your T cell recognize a virus. Well, you're looking for something that you've had nothing of before, and then all of a sudden the virus comes in, it starts replicating, and you have a lot of it. And then at some point, if you get rid of it, it'll come back down to next to nothing. And in that period, you mount an immune response, and you learn it, and so the next time around, it'll be faster to respond to it, and keep you from getting sick.

That's one kind of signal. but self can have either one of two signals, I think. One of them is that you've had it your entire life. So that amount of protein, maybe it's insulin, you know, which we think in general, you know, it has a little bit of signal up and down as you have a trigger, but there's a range for that. And so your body gets used to that range and the T cells that see insulin, they are very low. They're gonna only be very, very low reactive to that. And there's a whole story behind that, but basically they're gonna see that level.

But you can also have things that the immune system is going to want to treat like self that maybe do a slow rise. They don't have this peak that you have with viruses, so like a mutant cell, and maybe it's just a tiny, tiny bit above normal for months, and then it makes two copies of its cells, and now it's a little bit higher than normal. And the immune system has, I think, one of the deficits with cancer is exactly that, that things that you do, and this is sort of like I try to live my life a little bit this way, but it's not validated by any experimental stuff, but it's the idea that whatever you are is what the immune system is going to help you be.

If it's a slow direction this way, it's going to be okay with that. What it doesn't like is like big spikes, and that's maybe the signal that you're asking about. Like, could you actually get to the point where you'd be interactive? The problem with cancer is that it is slow and it grows over time, and I think we're made to absorb slow change because if it's not causing us to be sick yesterday, and a a little bit more of it isn't causing us to be sick today, then it's probably just a developmental change. Maybe it's a new bacteria. Maybe it's a new ... It's commensal, as long as it doesn't accompany ... Again, viruses have two features in common.

One is the spike of appearance, but they also cause damage in that window. You have these cues that I think the immune system ... I say the immune system because it's some cells are going to see the damage and some cells are going to see the additional proteins that come in, and then they exchange information just like your brain. You can talk about the fact that the brain has this wired set of cells that are wired in space across your body from your brain all the way to a muscle, let's say. The immune system has this collection of cells that are literally crawling around to us right now.

We still do a lot of imaging. If you look in a piece of skin, you can see the immune system are really, really surveying us. They're crawling around. But they get together like neurons and they can form synapses. One can say to another one, this is what I saw. He says, oh, you saw that. well, I'm just doing this. And they can form a cluster of cells that basically get together like a neural little mini brain in our tissue. And they can say, this is bad. We got to do something about that. But I think the slow burn doesn't do that.

The slow burn is one of the ones where the cells are like, yeah, it's not that bad. I realize this perhaps is not your immediate area of research, but recently I've been seeing a lot more interest in the thymus, this organ that we have when we're young and it disappears as we get older. and there's a lot of interest in the thymus maybe because we've never covered the thymus on this podcast in any amount of detail. If you could just educate us a bit, what it is, what it does, and why it might be interesting as a therapeutic. I mean, maybe in a few years we'll all be banking our thymic cells.

Maybe we will be, I know some people are already injecting non-FDA approved peptides that come from the thymus. I'm not recommending anyone do that, but people are already doing it that's the internet in 2026. What's the thymus? What does it do? Why this interest? Yeah. Well, I can back up one step and I've used the word T-cell before. And T-cell, originally was thymus cell. So for those that maybe don't, you know, have gone to have blood taken, you know, if you have blood taken in a hospital, whatever, you'll get red blood cells. And those are the cells that carry oxygen around your body. And then you have white blood cells that come in two flavors. Well, they come in multiple flavors. But for the moment, We'll talk about two.

One were called B cells and one were called T cells, and T cells were named because of the thymus. So the thymus is this funny organ, and it has a funny history. In fact, I'm writing these sub stacks these days, and I'm writing one that's supposed to be released tomorrow about the thymus because it really should have gotten the Nobel Prize. There's a guy who's alive, he's like 97 years old in Australia, who did this remarkable kind of experiment. There was this time when kids that had heart issues would come in for surgeries, and they They would discover this enormous whitish organ as growth near the heart as they were taking the body, you know, as they were cutting open.

And all the autopsies up to that point had been done mostly with adults, and in adults, there's only this small little thing there. And so they were like, oh my God, part of the heart thing is this overgrown thing. They didn't really know what it did. And so they would remove it. And the kids then go home, and it was usually exploratory heart surgery, but the kids would go home, and far from dying of heart disease, many of them would die from opportunistic infections. They'd get all these infections. They'd get flu, et cetera, and so there was this hint that maybe this removal had taken out a critical part of your immune system, had made it so you were super susceptible to bacteria, and so this guy named Jacques Miller, who's this nice seven-year-old codger in Australia, at the time he was in England, and he basically took a bunch of mice, and their newborn, he removed their thymus, the same little whitish organ.

And sure enough, those mice, they basically grew up, okay, but then they all would succumb to bacterial infections. And in fact, a few of them even got tumors, which was kind of noted at the time, but forgot. And the reason why that is, is because the thymus is the place that makes all your T-cells. And it comes from a kind of a convoluted path, but when you're talking about how the stem cells of your immune system lives in your bone, well, there are some cells that live in their bone, and they travel through your blood to the thymus and become T cells.

The reason they need to do that is that the thymus is this kind of super special place that is able to present to them, to show them all of the genes in your genome in various different ways. The T cells that come in there, the T cells are developing, and they each have a possible 10 to the 11th different kinds of receptors to smell different things. You don't want any of these to come out that are too reactive to you. You don't want to produce T cells that are going to go off and kill your pancreas or kill your big toe or anything.

You want to maintain tolerance, so you want to make sure that you don't make the immune system that's too harsh. So the stymus has the role of producing T cells, but also of educating them in some ways, of only letting the ones that come out, that have sensors that are correctly tuned to let you be you in that way. Now to the point about the story, and you were asking about aging, is that in kids, Those are really big because at that point, we were talking about the developing immune system. It has to go from living under the veil of your mother's immunity and then it needs to let some development happen and then it needs to burst out and start to be able to react against whatever bacteria and viruses you're going to see over life.

So your thymus has a huge output. So as a like between really from three to six months old and into your four or five years age, but tapering, your body makes tons of T cells and it's because probably what you're talking about. You're getting exposed to all kinds of different bacteria and viruses, and so you need to make that collection of immune cells that both some of them see self at low levels, but then they also can maybe react against different things in the environment, including the ones you need to defend against. Then what happens is because, again, I think we're not needing that later, and maybe we don't even want that, the thymus involutes.

It gets super, super small, so that in aged people, it's tiny, and so it's not putting out new T cells. So the reason why there's interest in like these peptides, but all these other approaches to like revitalize the thymus is that like in cancer, for example, wouldn't you like to have a whole bunch of new T cells that could come into you flood in there with exactly the specificity for the tumor? The tumor has managed to teach all of your normal cell, your other T cells in your body that it's normal. Maybe you need a source of new material to come in and do that.

And there's really two ways. I think you mentioned you talked to Alex Marson, not too long ago, and I'm sure he would have talked about engineering cells that you can engineer on the outside and give them specificity. But the sort of like, if you will, the more natural route to that might be to let the thymus make use of more T cells and make sure that as they come out, you make sure that they can react against this tumor or whatever it is you need to defend against. It's always been a fascinating organ from the sense that it's the origin of all the cell types that we care about, the T cells in that case.

But it does have this sort of aging effect that seems to make us a little bit more susceptible to things later in life. And again, we could argue about whether there was a big evolutionary design behind doing that or whether it just wasn't needed. Because you got to 30 and you died of an arrow wound, but you've given it genes. You're a winner in the evolutionary sense. I love this stance on, well, if you've already reproduced it, I'll just give a brief vignette. We were introduced by our mutual friend, David Feltime, who's a phenomenal developmental biologist from UC Santa Cruz, and his wife, Sophie Salamas, also a phenomenal biologist, a mutual friend.

Years ago, I was in Dave's lab because we were longtime collaborators and published a bunch of papers together, and he was doing some injections. I'm going to get you in trouble, Dave. He doesn't do this any longer. Yeah, I'm gonna join him to get you in trouble because we both love you a lot. He was doing some injections and he might have been using, might have been using carbocyanide dyes. So it's kind of a conventional tool back. You put a little crystal in a piece of tissue that's fixed tissue, so it's not a live animal or anything. And then you put it in the fridge and then the fluorescent dye would label a set of neurons in a pathway.

And I walked over and I saw Dave doing this and he wasn't wearing any gloves. And I thought, these are carbocyanide dyes. With cyanide being the empty. And I said, Dave, don't you want to put on gloves? And he literally looked up from the microscope and he'll never forget. And he said, I've already successfully reproduced. And he went back to doing it and it's his lab. So, and everyone else was following a safety protocol. Don't go after him. He doesn't do this any longer folks. But there's an interesting mindset among you because he comes from cell biology, Randy Scheckman's lab.

You both trained in Nobel prize winning laboratories as graduate students. So I find it remarkable that this stance of, well, if you've already successfully reproduced, it really aren't needed, but his kids are now graduated or in college. So there is this thing about raising the young too, and not just creating them and then dying. I agree. I think there's a fitness associated with being older than that. And again, when I say that this, it is maybe just taking this from a purely like, what would have been the source of what we are today? What would have been the selective pressures on them?

And it would have been a little bit like, David, saying the selective pressure is to get your ... For my genes to be passed on, my offspring have to be born, and then have to get to some age because most humans are born pretty incapable for a period. It's not like Jurassic where they drop out, and they drop out, and within an hour they're running. So that period of raising children, I think, creates more pressure in humans to successfully be healthy longer. But I guess just maybe a negative viewpoint, but that concept that maybe there isn't as much pressure for you to be healthy. And going with this is the idea that some of the things that we want to be super efficient early on might actually be bad for us as we get ... I think this issue that I brought up with our mosaics is a real confounder to everything because that creates something that is quite hard to defend against, I think, that aging backdrop and some of the immune system that is really going to be important to just be super reactive early on may have some compensatory problems when faced with that new reality of a 50-year-old or 70-year-old or whatever that looks quite more complex.

But you would have definitely wanted in gene space, in a gene space, what genes you have to select for an immune system, let's say, or even just your body system that makes sure that you get to 30. Let's say, who are you? Again, it isn't to say that we can't overcome some of those deficiencies if we understand them, but here's my plug for basic research is that to understand them, we have to ask some questions that almost 90% of them are going to be dead ends. You cannot hypothesize it's one thing, but you got to do the experiment to eliminate that. This is one of the things that people I don't think always understand about science is that for all the discoveries that I've made or other people have made, There are hundreds and hundreds of disappointments, and you'll recognize this where you just go home from the lab at the end of the day and you've done everything right, but the answer isn't the right one.

One control experiment can nuke your whole project. Well, there's that. One good control. There's obviously that you have to do the experiment well and have it controlled, but the answer just could be not the one you thought. We can only imagine stuff and then try and see if it's true, or more importantly, try to prove that it's not true, and so the better experiments, we call them killer experiments, right? They want to kill the idea if they're wrong, if the idea is wrong, but it's killer because if it turns out the way you hope it will. Again, when we get to some of these aging things, there's a lot of intuition that we all can put into this, whether we're like professional scientists or at-home scientists, but it's really hard to say that intuition, like your idea about how the way the world should work is in fact the way the world does work.

I wish that because of the age certain things would happen. That's lovely, but it could be super, when the word was baroque, the whole system could be configured in a completely weird way that doesn't really initially make intuitive sense to us. That's also why some of those discoveries are so big to us. We're like, oh my God, I didn't realize that this system that seems like it might be quite simple is so complicated. world is so strange. Well, when I started in neurobiology, the brain, actually the entire central nervous system was considered an immune privileged organ. Yes. There weren't supposed to be immune cells there. And thanks to the beautiful work of Karla Schatz with the major histocompatibility complex work and Ben Barris. Ben Barris. And I'm failing to mention all their scientific offspring, Beth Stevens, Shala Erglue, Ben on and on. They would take the rest of the episode to name all of Ben's scientific offspring and Carlos too.

And you're convening you. Right. I didn't work on those issues, but I was in those labs when it was happening. We now know that the immune system is active and alive in the central nervous system throughout the whole lifespan serving critical roles. There are two things that, well, three really that are somewhat practical questions. I'll start with the most basic one. Why is it at a mechanistic level that if you You miss a night or two of sleep that your immune system seems so less effective in fighting off infections. Do we know what's happening? Is it like you've got so much adenosine, which is the sleepy molecule, and that adenosine inhibits T cell function or something?

Do we actually know? Because I think all of us are familiar with the fact that if we don't sleep well or enough for a couple of nights, we're much more susceptible to getting sick. Is there a mechanistic understanding of why that's so? I think there are bits and pieces of it. But I think some really nice work shows that at night, a few wacky things, when you sleep, a few, what you might've thought would be wacky things happen, and one of them is that a lot of your immune cells clear back to the bone marrow, and your tissues become populated with a bunch of neutrophils that come out of the bone marrow and seem to be depositing collagen around your body.

And so there's a lot of things that I think are reparative about sleep. I've thought about this a lot of my own life, as probably you have, with sleep. One of the questions, of course, is why do we bother to have sleep? I guess I can only imagine this because we've created these bodies of ours are so capable and they're so energetically consumptive and they make all these byproducts during the day that at some point you just need a clean up phase. That's one interpretation of sleep, you just need to reset. The immune system is definitely resetting and, as I said, there's evidence that a lot of the cells go kind of quiescent into the tissues, and they may leave you alone for those reparative processes and actually allow those.

In terms of the data on there, there's a lot of studies that are being done, and I can't say that I've come to a conclusion about that. This comes in the question of like, is it known, or do I not know it, or does nobody know it? And I'd say this might be one of these areas where about 10 factions of people know it, but they don't agree. So, there's variations on things, but I think the data, for example, that immune cells dive into the bone marrow at night is pretty solid. That makes sense. What they're doing and why that's important in the long sense of like what you're talking about, everything from...

Well, but I think it's things that happen overnight, definitely your cognition improves. Is that immune or is that neuronal or both? I think it's both. Something in the lymph plumbing immune system, one thing that's just striking like that is is undeniable is probably the best way to put it is, everybody has bags under their eyes and looks like shit when they are sleep deprived. They sleep for a night or two and it goes away. That's clearly accumulation of lymph. We actually know that. That's just lymph fluid that's not being cleared. And it might not even be the brain's glymphatic clearance system.

It's just, there's a bunch of lymph pooling under your eyes. That's why you look like shit. And then you sleep for two nights, well, and then you look better again. And the eyes get glassy. We know that the eyes get glassy when we're sleep deprived. That's also a lymphatic clearance issue. This is well established. So there's some things that are just like plumbing works better when we sleep and get up again. There's something literally about lying down and getting up. But that to me can't explain the immune thing entirely because like the lymphatic system is like, among other things, immune surveillance.

But I mean, one night it's lousy sleep and the person coughing across the room gets you sick often. But when you're well rested, you actually feel this robustness like, man, like, okay, I might wash my hands or just kind of avoid them and you're good. So it's, I mean, it's an incredible effect one way or the other. Again, I don't know the degree to which we can nail down, you know, which part of things that are happening is which I always liked the story that the, there's macrophages in me and cells in your eye that are basically clearing the lens.

You know, so there's all these like places where it's doing little cleanup that you can imagine that if the thing it's trying to get rid of is granularity that you need to have sleep where you just aren't making more granularity so that it can, you know, sort of like when you wash your car windshield, you do it completely at that point. But you can't be driving with flies hitting everyone, right? Or you'll never clear. That's a great analogy. You know, so I think there's certain elements of some of these cleanup processes that happen best and you're not getting things dirty.

Or again, I think a lot of what we're talking about is byproducts of our energetics that leave some damage behind it. I think we just use a lot of ATP and we do a lot of stuff as our bodies in the sleep is this time where you can not be producing more of that and get ahead of the curve on cleaning things up a bit, like pulling into a gas station, cleaning off your windshield. I'd like to take a quick break and acknowledge our sponsor, AG1. I'm excited to share that AG1 has just launched their newest formulation, AG1 Pro. AG1 Pro takes the clinically-backed AG1 formula, which is a blend of vitamins, minerals, probiotics, and adaptogens, and adds three important new ingredients, creatine monohydrate, calcium HMB, and zinc carnosine.

Each serving has five grams of creatine monohydrate to support muscle strength and performance, as well as brain health. Calcium HMB to support muscle recovery and reduce muscle breakdown, and zinc carnosine to support and improve the lining of your gut. All three of these ingredients have compelling science to support them, and therefore I love seeing them added to the existing AG1 formula. As most of you know, I've been taking AG1 every day for nearly 14 years now. I started taking it long before I even knew what a podcast was. It's a great product and it's now made even better with the new AG1 Pro formula.

If you would like to try AG1 Pro, you can go to drinkag1.com slash Huberman to get a special offer. AG1 is giving away a free bottle of Omega 3 Coenzyme Q10 with your first subscription. Again, go to drinkag1.com slash Huberman to get a free bottle of Omega-3 coenzyme Q10 with your first AG1 subscription. This thymus thing is really intriguing. And I know a lot of people who opted to bank their child's umbilical cord in the hopes that the stem cells from the umbilical cord will someday be useful. How invasive is it? And or should we be banking thymic cells? Because these seem like incredibly valuable cells for their ability to immune surveil and create kind of the perfect situation using our own endogenous T cells to battle infections.

I mean, I kind of wish I had a little chunk of my thymus in a minus 80 freezer someplace so that when I'm 85 years old, you might be able to exploit that. Yeah. Well, I'll say that the umbilical cord one is pretty straightforward. It's, you know, the umbilical cord is being essentially discarded anyway. and it contains a lot of, as you know, bone marrow stem cells, that the utility of those is a little different than the thymus. The utility of banking that material, and banking just means you put it into a vial, small little vial with media, and you set it in a very, very cold environment for whenever you might need it, is that if you need to have a bone marrow transplant, so for example, if you have a tumor of the bone marrow system, you can subject yourself to radiation and wipe out all that tumor cells, but you'll wipe out all the stem cells.

But if you get this vial here, you've got a little replacement. Has that ever been done successfully? Yeah, yeah, you can do- So are there- Autologous- Are there kids that- I mean, kids are adults that are alive today because they banked their umbilical cord. But certainly companies sell access to that. Well, somebody has to pay to keep the freezers on backup generators and things like that. So people invest time and money into this idea. Is there a walking, talking, breathing human who would be otherwise dead, would otherwise be dead, excuse me, Because they paid money to bank their umbilical cord.

It's a really good question. I don't know the answer to that question. I guess the parents paid. I can tell you, and this will be just like, this is the depth of to which you're describing default, I'm injecting a mouse, is that in mice, this is true. That if you take bone marrow stem cells, you can reconstitute a mouse with a blood cancer and you can do that. I'm sure you can do it in humans too. I have zero doubt that it also works. I don't know whether those companies have done that. that's just actually something where I whole of my health.

This is offered in mass now. Yeah. Maybe it's more than, do you want to keep the umbilical cord? Honestly, I would do it because it's one of those situations where if it's not too, well, I don't know if it, depends on how much money you have to spend because the cost is not- That's something that's within the noise, yeah. Yeah, it's one of those, so it's one of those ones where particularly when you have kids, there's this whole aspect of like, I would like to protect them from anything that could come their way and I think this would, if they happen to have a childhood leukemia, this would cure it.

Which is an incredible statement if you think about it. Even if it hasn't been done successfully yet, you didn't say it might be able to lead to a cure by virtue of a new technology. You said it would cure it. I mean, that's a big statement. You can tell I'm ratcheting up from like sleep to banking thymus and umbilical cord. Now I'm gonna go to the sort of next level, which is not just in the Bay Area. A lot of people, however, are starting to think about, Oh, maybe I make some induced pluripotent stem cells from a fibroblast from one of my skin cells, put the so-called Yamanaka factors on, revert to stemness, and then I might be able to grow a new pancreas or study my, you know, whatever organs in the so-called organoids or whatever they refer to.

But I learned today from you that if I take that fibroblast now, that fibroblast might not be completely Andrew Huberman as I know him to be genetically. it's actually could have some mutations, that seems important to compare against a sort of standard cell. I don't wanna grow organoids from an IPS environment that carries mutations, that seems like a bad idea. Because then anything I would, I'm not talking about transplanting in those organoids, I'm talking about studying them, thinking I'm getting information about them, people are doing this. I'm thinking, oh, I'm seeing what drugs are effective treating a liver disease or a heart disease, but if those are mutant cells, that's a lousy experiment.

Yeah. I wouldn't say they're likely to be mutant cells for that reason. I think the biggest question would be whether your induction of them to become the organ that you want was successful, was replicating the actual organ itself. So you're referencing these things called organoids, which are collections of cells from a body of a human, for example, that are induced with various different factors to grow to to resemble maybe an organ, a particular organ. I think all of us have little doubt, and this is the source of the California Institute for Regenerative Medicine, that making stem cells that can become particular organs will at some day happen.

We will figure all these things out. I believe in science. I believe in our ability to test, learn, test, learn, test, learn. How soon that becomes useful is a bigger question. If you take out your fibroblasts today, that might only cure you someday in the future. And meanwhile, you may die of that thing that you wish you had the stem cells in because it's not yet ready. The technology and the understanding isn't yet ready. But the other problem with those is you probably will die of something else, head by car, it won't help you that you've got those things back.

So I think in some of these cases, like overemphasizing, this might be your point about the storage of umbilical cords, is like at what point is that a high odds situation where your kid needs it and you have it stored away, versus all the other things, fates that can be flawless as humans that have nothing to do with stem cells from the bone marrow. And to me, that's a point where you could spend your life worrying about how you're going to die, and maybe that's not a good way to live. Well, it's certainly not how I live. Right now, there's a lot of kind of excitement and attention around so-called longevity at the extremes of never dying or living to be 120, which seems to be perhaps the genetic limit currently. It's not my fascination. I'm more interested in living in the years I've got, as it seems you have to. Yeah, vital, healthy, you know, being able to move, sense and think, seems like, and remember, you know, those seem like the critical ones.

You know, a moment ago you mentioned the concept of like removing a bit of thymus. And I think that the issues for me with that are, you know, it's an invasive surgery. And like, if you were to take out thymus, it would, it's not clear to me that it's the thymus you need. You might be able ... I mean, in fact, you can make thymic ... The thymus is both the cells that come into it from the bone marrow, so as an organ, it has contents, but its structure are some thymic epithelial cells, a kind of cell that make a matrix that all those cells live in and they get educated in.

There's definitely pretty strong work that says that you can create a thymic epithelium that will do some of this work, but whether a guy at home could hold on to the thymic cells and we would be in a position to do something important for longevity in our lifetime, I don't know. I honestly don't know. In my career, I've seen things happen really fast, so fast that almost like you didn't realize that you're doing it. You're like, oh my God, we've got a cure for cancer. That's great. Okay, let's go on to the next thing. Two things that, so you're like, the California Institute for Regenerative Medicine, we thought that we would have some stem cell therapies, you know, within the seven or eight year window of that bond, first bond, and then there's a second bond.

We didn't really get very many out of that. We learn a lot, and that is the risk- About stem cell biology. About stem cell, about biology, and that is the risk we take when we do research. You know, we were talking a moment ago about how many times you might be in a lab spending hundreds of hours and not getting anything that you understand, and then one hour and you understand everything because, you know, so all of a sudden all those failures make sense. when we get into some of this stem cell biology, it's intuitive and it's almost certainly true that we will have some of these things. Whether we will have them in time for you or me, I don't know. I just don't know. And I think that's true of a lot of these things that say, oh, we seem to be right on the cusp right now, for example, in cancer therapy. We've been on the cusp for 10 or 15 years of these things called CAR T's. Alex will have told you about these, where you engineer your T cells and you give them special receptors that can get them to go into to eliminate tumors. But for whatever reason, they haven't worked in patients. They haven't worked. They haven't worked. They haven't worked. And T cell, the immune system gets turned off.

These cells don't make it. They don't fail. They failed to eliminate the tumor. We will figure that out, but we've been thinking that we've figured out, you know, sort of for five or 10 years. And it's, you know, that gets frustrating. And I think it gets frustrating for people that are like waiting for it to, on the outside, like, why can't you solve this? And you're like, well, because the universe isn't always configured how we think it is. And that's discovery. That's the problem of discovery. If we knew what we needed to do, we would engineer it and it would work.

This is an important discussion that we haven't spent enough time on in this podcast that I think is very important for people to hear. And I have some thoughts about it, but I'd love for any disagreements. I'm not looking for just agreements. So my observation from a couple of decades or more doing science and then mainly shifting to podcasting, but but this is what I do, I talk with great scientists. So that's the podcast, so I'm very immersed in like what's happening right at the cutting edge and because of great guests like you. You know, my sense is that in every field there's been like this kind of steady pressure, like water on rock pressure, like, okay, we're gonna understand like salamanders regenerate.

Wouldn't it be great if we could do that too? Cut off a limb, it could grow back. Okay, amazing. I think it's like Ellie Tanaka's work has just shown that. You're like, wow, this would be incredible for amputees and brain regeneration but then it never really transfers. So we're like, oh, we're gonna figure out ways to get genes into cells. We're gonna electroporate liposomes. We're gonna use a calcium phosphate at like great research tools. Tons of things happen. And it's like, we're gonna modify genes, zinc, finger, nuclei, so all this, okay, CRISPR, boom. And one thing just breaks through and goes so much further.

And even though, you know, the ethics are questionable, there are babies that have deliberately induced gene alterations with CRISPR, sickle cell anemia treatments as well, some more benevolent example, but then the person who went rogue and just kind of did this in humans in China. But CRISPR just kind of broke through it all. The excitement about stem cells led to like, yeah, I mean, even initiatives at the legislative level and like all these labs working on things. And then as you said, it's kind of like run up against the dam. But I feel like in 10 years, some or all of that information will be extremely relevant when boom, one thing will just like leap out of bacteria or like grasshoppers, no pun intended, with the grasshoppers.

But the last example would be, you know, for years, it was like the country's getting fatter, the country's getting obese. What are we gonna do? Do calories matter? Of course, calories matter, this kind of thing. Energy, you know, laws of thermodynamics still apply. And then all of a sudden, this fricking Gila monster biologist tells people what they already knew because the GLPs were already being used as a drug, just not at significantly high levels. And all of a sudden we have a imperfect, but very important, more or less, dare I say, cure for obesity. It's got problems, there's muscle wasting, there could be other issues, apathy, et cetera.

I'm not trying to discount any of that, but I feel like that's the way science works. It's like steady pressure, steady pressure, steady pressure, frustration, and something comes out of nowhere. And it almost seems prerequisite to have all those years of frustration and failure. And you say, well, couldn't we have just gotten CRISPR first or the GLPs first? Like, why did we go through all these, you know, billions of dollars of expenditures, time, energy? Yeah. I don't know. I feel like there's some natural order to this. And I just would like your thoughts on, I feel like it's necessary, but not sufficient to have lots and lots and lots of failures.

Yeah. And I think it's necessary and necessary, absolutely necessary to study things that are just at some point curiosities. And that sounds like science is about trivia, But, you know, you gave an example clip one, somebody was just curious as to why HeLaMonsters, the feature was that HeLaMonsters can go into dormancy for like 10 months, not eat, and then come out. And like, how do they manage that? And so that was just like, what is that? What causes that? CRISPR. You know, that was people were studying like, how do bacteria defend against other bacteria? Well, they use this, it turns out there's this enzyme in it, and it remembers the sequence of this one bacteria that has come and invaded you before and then can modify the genome and get rid of it and kill it.

That same enzyme then, which we now use for all this human engineering, came out of a basic like how bacteria defend themselves. It's not anything about modifying sickle cell anemia. It was about how does the world work. My career is exactly as long as the lifespan of this field we call cancer immunotherapy. I did the first immunotherapy experiment. I injected a mouse with an antibody that I had made. It was against molecules on T-cells, and I'd shown already in the lab that that molecule caused the T-cells to get more activated when you blocked it, and we did a series of other mouse experiments of all kinds of diseases, and it kept jamming up the T-cells, and then Jim, I said, we got some tumors in the fridge, and so we set up that experiment, and injected this antibody, and the tumors melted.

Well, that was the start of cancer immunotherapy, really, and that's the origin of it. This is the experiment for which, let's just be direct here, that your advisor won the the Nobel Prize. Right. Correct. Did you at least get to attend the ceremony? Yeah. Yeah. That was a little thing. This is how science works, folks. It doesn't matter who did the experiment. Yeah. It matters what lab you're in. You know, you get to go to the after parties, we're good. But I guess I'll take you back. We weren't trying to cure cancer when we started this. The thesis project, when I went into Jim's, my mentor at that point, the discussion was like, well, there's some molecules on T cells.

And I said, you know, we knew from AIDS and a few other things that T cells were important. So that was the attraction, even though you had people say, why would you do immunology? Well, they seem to be interested. And there was a molecule, and I was like, well, yeah, let's just see what it does. And once you saw you could turn things off, then everything became possible, right? Now you set an immune system, you can dial up, you can say, well, if I could dial up, what will happen to vaccination? Well, it got better. What will happen to multiple sclerosis?

The disease got worse. What will happen to cancer? Ooh, we can start to have an effect on it. And the X-ray, the people were studying physics, and then it turns out to be that they were we're like, oh, I can measure bone. And that's how we use x-rays now. So there's all these examples that everything, the big things often come from these orthogonal directions, and then we realize what it might mean. And I think you have to start there. Otherwise, you'll just plow this direction and you'll hit those walls because you don't have to work around that comes with some orthogonal piece of information, a orthogonal meeting at right angles, right?

So, again, CRISPR came from bacteria, but it's really useful in us as an engineering tool. But we wouldn't have known that if somebody hadn't been out there sort of saying, okay, well, how do bacteria do it? How do they defend themselves? Oh, they use this enzyme. And I think that's a really important message that dispels this idea that everything is sort of like basically just easy for us to engineer. Yes, once you have the CRISPR tool, it becomes actually kind of easy to do some really cool things with it and still creative. But the fundamental leap that you're describing, I don't think in many of those cases that people were kind of conceiving they were in the first dregs of doing it, this would become an industry, this would become a whole thing.

And maybe that's important because you need to foster that. If everybody always thought they were doing it to build a company and sell a product or something, then I don't think we would do the things that get us new. That's all kind of what we already know. That's human knowledge. We want to build human knowledge. And to build a human knowledge, we got to go off piste. You can't ski on the slope. You got to be like in the trees and maybe you'll bonk your head a bunch of times. I think that's the reality and it's like you got a lot of people out there that have decided to do that for a life because it's a chance to like solve a puzzle.

It's like there's puzzles about how the world works and if you've ever done a jigsaw puzzle with your family, there's always like, oh, you get in and especially in the end, you're like, how do you know what pieces come together to do it? I think that's what makes this whole science thing really fun. That's the reward is that you get the puzzle piece in and you're like, oh, it makes sense. that now I know what I've been building. I've been building this puzzle. And then you go back and you do it again because that's really satisfying at the end of it, even though, again, with the family puzzle, the first parts are so hard, thousand pieces and you maybe find the edge, but the intervening where there's like all clouds, super hard.

And I think that is what science is a lot about, is doing that and then realizing what the picture is, what is that picture of it? And then all the breaks are off. I often tell people that if an experiment you'll do in lab has a 10% chance of yielding anything interesting, you gotta do at least 10 to even meet the fundamental stats. You actually have to do quite a few more. So that's where it's not a cost-effective thing if you, it's really difficult to be a scientist because there's no quid pro quo. There's nothing to say if you put in five hours that you'll get five units of goodness, of knowledge out of it, a lot of times you get zero.

But then sometimes you put five and you got 500. Right. And those are the jackpot moments where you're like, It's like life. It's like life. It really is. It is. I have to say, anyone who's considering a PhD, we had a call in from an audience recently, and someone said they're finishing undergraduate. They want to go, or finishing graduate school, should they go the research route? They want to do a postdoc. And I'm like, yes, yes, and yes. Rather than answer publicly, I decided to just have a call with this individual, because it's a rather niche question. But I mean, also just in training your reward system to work for five years on something is so valuable, especially in this day and age, because everything else feels like it comes at like warp speed.

Yeah, so it clicks. Yeah, and to just put steady pressure on something with all the failures and all the things, and then to finally complete something, a lot of people think it'll be underwhelming. I think quite the opposite. It's like anyone that's done a triathlon or raise the kid or done anything, you're like, oh my goodness, and that never ends. There's nothing better than these long-term investments, nothing. When they break through your analogy, when you break through that dam or when you realize sometimes that you broken through the dam, that's one of the funny things about, I think, science and maybe it's true in triathlons and stuff too, where you've realized that you've all of a sudden got somewhere.

I haven't done a triathlon, so I have to be fair, Rob, our producer, to our left, he has has done many Iron Mans, and he has that mindset of just steady pressure. I mean, his relationship to work and effort is remarkable because he burns so little energy worrying about things that we refer to as in the left column, like the stuff you can't impact and just focusing on what you can impact. And so a lot of it is about learning energetic control, like doing science that is, or anything is about what not to think about, what to force yourself not to do or think about.

If I may, I'd like to shift us to this very interesting area of immunology and biology, which you refer to as spatial biology. And I'm gonna pose a question that may or may not fit with this framework, but either way, I'd like you to educate us on it. I'm fascinated by these old kind of barbaric experiments in medicine. Wonderful book, by the way, folks, is The Prince of Medicine about Galen. If you ever wanna learn about how we learned about medicine back when it was truly barbaric, it was like surgeries done on warriors and without anesthesia. And we've known for a long time that if somebody, God forbid, has a finger lopped off or a hand lopped off, that might actually be a worthwhile investment to make an incision in the gut and stuff that thing in the gut to keep it warm and keep the tissue viable for regeneration once you try and put it back on.

Turns out that's true. Is that true? Yeah, there's a bunch of juicy stuff in the gut that maybe it's the warmth, maybe it's the immune system. Maybe it's the lack of infection from being inside as opposed to outside the body. Who knows? Do you mean the intestine or you mean the stomach? Within the stomach. The stomach itself. Yeah. I'm not suggesting anyone do this experiment. As I started reading into this, I discovered that there are a lot of really cool experiments, not just in limb or tissue preservation and restoration. Like for instance, I've talked many times in this podcast about the fact that above the roof of our mouth, we have this small cluster of neurons, the suprachiasmatic nucleus organizes the circadian rhythms of every cell in our body from the genetic to the transmitter level, peptides, et cetera.

It keeps us sleep-wake cycles, does all the organization that we need for circadian rhythms, so much so that you can take just one subpopulation of these neurons, the Kalbindin expressing suprachiasmatic nucleus neurons. It's like 5% of the total neurons in this already tiny cluster of neurons, and you can transplant them pretty much anywhere, and certainly in the brain, and you'll restore the circadian rhythm of an arrhythmic animal. So that tells you a lot of cool things. It says, okay, there's probably something that secreted or, but like these cells are that important and it doesn't really matter where they are, at least in the brain, they can do what they need to do, which is super cool.

And then I started reading about, oh, like you could actually take perhaps like a little bit of pancreatic tissue and like stuff it in the, you know, under the skin. It's not ideal, but you get some function back. So I'm fascinated by this because we like to think that the organization of our organs is so critical, but maybe they just need to be there. Now, no one should test this hypothesis unless they have to, but when we think about the immune system, you described the function of the thymus beautifully, you talked about the bone marrow, but you also talked about the massive migration of these cells that are working in this network.

How important is spatial compartmentalization of these cells, or is the rule, eliminate spatial compartmentalization in order to make the immune system function at its best. And there's a very specific practical question which I'm asking this, but I'm just gonna tuck that away to peak people's interest and I'll get to it. But this is relevant to important decisions that we make, I believe. Well, the answer is yes and yes, it's both. So although I described the immune system in the earlier part of this discussion as super migratory and it just arrived in the blood, gets into tissues, it travels through your lymphatics.

there are these things called lymph nodes down the lymphatic tubing, which for those that don't know, lymphatics are like drainage. It's how you drain the fluid back out of your tissue. So although there's these mass migration of cells, there's also in, like even just in T cells, there's T cells that lodge in particular settings and they act to protect that tissue and the resident cells of those tissues, they never leave. And so both are true. You have parts of your immune system that are protective or nurturing of particular areas, and then there's ones that are circulating and can hit any spot.

Going back to your idea of organs and such being moved, I think there's two components to that that you might be thinking about. One of them is the question of whether the organ can survive in the new space. Does it have the growth factors and the blood flow and the lymphatic outflow and maybe even some neuronal activity that makes that tissue work? That's where like if you take the pancreas, you can famously put it underneath the kidney capsule. Kidney has kind of like a skin around it. You can tuck some pancreatic cells in there and they're super happy. They love that.

They get all the blood flow they need and it seems to be just right for them. But if you've got somebody with diabetes, for example, and you try to put new pancreatic cells in anywhere in their body, the immune system will attack it just as it did the first ... Diabetes for those ... Type 1 diabetes is caused by the immune system that gets too active against the pancreas. It's autoimmunity. It's where it's now saying the pancreas is not self, it's something foreign, and it wipes it out. And that's the source of what I said earlier, like your immune system can be quite dangerous.

So when you talk about this concept of spatial, there's a few things to bring in. One is, can the organ get what it needs? And then does the immune system accept it in some ways in that environment? And that's where some of your immune system that lives spatially in certain areas is going to be very defensive against whatever it's specific against in that area, but may not care what's happening elsewhere because those cells just aren't ... It's not like the brain where you're like, if I do something here, it's sensed in my brain. Immune system, if the cells don't migrate, they don't have really a lot of ways to communicate. They can hitch some signals on neurons, and that's a really interesting thing. We could talk about the capacity for your brain and the insular cortex. There's a great set of stories emerging about how your insular cortex can program your immune state into organs and via the vagus can essentially program- By levels of calm or stress or by thoughts themselves.

Well, the latter one is the one that gets me super excited about the possibility that you could have triggers for thoughts that ... So the insular cortex, as I understand it, it's a source of some of our moral decision-making. It's also thought to be the part of our brain where if you cut your hand and I see it bleeding, I can feel it in my hand. I go, oh, ow. It can sense and you can sense each other's pain. It's a set that this very nice Israeli group, Roy Slab, did this very nice study where they induced into the guts of mice inflammatory bowel disease.

They fed them a really weird sugar that causes the bowel to puncture and then they get a really bad stomachache, inflammatory bowel disease, diarrhea. In that period, they used what dreads are, so they marked for the crowd, they used a way to mark all the neurons that were firing during that period in the insular cortex, and then later they could fire them after the mouse had recovered, and they saw evidence that the immune system was resetting up itself in the gut as if it had just been punctured. The cues for that, in that case were a drug, but we know that we can cue the insular cortex like me watching you do things.

So it's always, it's made me wonder whether, you know, like some of the things we smell cut grass and we can instantly take us back to a whole bunch of thoughts about how we were when we were kids and maybe even make you feel a little like that, whether there's aspects to this, to which our ability of our thoughts to control that region are gonna be revealed to have potential that you could train, you know, train yourself to bring up an immune state in a particular tissue. And just so we make sure everyone's on board what you just described, because there's a lot there, if I understand correctly, we know that the nervous system can do contextual learning, like if an animal or human, just keep it to humans, gets shocked, scared, or traumatized in a given region, or even I've had friends visit San Francisco and get their cars broken into and their computers stolen, you can develop a context-dependent or place-dependent memory where you kind of don't like San Francisco as much, even though the rest of the trick was awesome.

That's a pretty broad interpretation. Or you have a great experience someplace. And you actually really love San Francisco because you met your future spouse there. You just had a particularly awesome experience there. Even if it was just in one part, you might feel better about your computer getting stolen anyway. Okay, Insula seems like a, you know, let's take the positive example. Let's keep it positive for a moment. I think what you're describing is that if we remember the positive thing, if there was a positive immune status associated with that, the immune system is also part of that contextual memory. And so merely by recalling the positive or negative, but in this case, positive memory, we can also recall, we recall not just the memory, but also the body state, and the body state includes the immune status that accompany the positive or negative event.

That's what these studies are starting to emerge in. That's cool, that's really cool because we've heard for so long that like, we know that chronic stress impedes immunity. We also know that acute stress boosts it. And that's something that, you know, with all due respect to my colleagues who've focused on the ill effects of chronically elevated cortisol, like the immune enhancing effects of acute cortisol and stress are really important. And I think they've been overlooked, but I love this because one of the problems slash luxuries that I have is I sit sort of at the interface between like real science and biology and like what most people perceive as complete nonsense wackiness.

But more and more we're finding that's within the complete nonsense wackiness, they're kernels of truth, like that you can actually meditate your way into a better state which helps serve your immune system and so on and so on. And that's seeming less and less wacky, even outside California, because of studies like the one you described. One of my friends who's a faculty, Dan Lippmann at NYU, we were talking about the same study and he was like, that may be what meditation is doing, because it may be allowing your brain to, you know, communicate and reset, you know, less inflammatory states across your body because of this axis.

And the study was really, I think it was, you know, there's still work to be done, but the, you know, the fundamentals of it was in the actual event there were certain cells that would accumulate in there. And then in the induced event, when you made the brain fire again of this mouse, you would see, you know, not as profound, that you saw, this evidence of these same sorts of cells accumulating there as if they, they're ready for that inflammation. And I think what we're talking about is the idea that you could have that go both directions. And again, the concept of, I mean, I'm sure you've talked about this before, of meditation, where the idea is that you, it's one of the ways that you can control your autonomous nervous system, is through your breath that happens with meditation.

I think that, to me, there's something intuitive about that, but I just, an hour ago, warned you about the problem of science being intuitive, that some things that make, they sort of make a great story in our minds that don't turn out to be true. But the data on this insert cortex thing is starting to look like it's a real thing. Like there's a real connection between some of the peripheral states and like regions of the brain. And however those are triggered, now maybe, again, I've lost that, well, maybe when you're healthy, you should smell like mint. And then when you want to be healthy again, you know, it's kind of crazy thoughts.

But again, there's an element of that that's intuitive to where you say, oh, that seems to be the case. My mom makes me a comfort meal. Is it really the meal settling in or is it just the sensations that make me feel like, you know, less stressed in one sense, but maybe also to this point and literally resetting your tissue. I'd like to take a quick break and acknowledge our sponsor, Function. Function provides over 160 advanced lab tests to give you a clear snapshot of your bodily health. This snapshot gives you insights into your heart health, your hormone health, autoimmune function, nutrient levels, and much more.

They've also recently added access to advanced MRI and CT scans. Function not only provides testing of over 160 biomarkers key to your physical and mental health, it also analyzes these results and provides recommendations for improving your health from top doctors. For example, in a recent test with Function, I learned that some of my blood lipids were slightly out of range. As a result, I decided to start supplementing with nadokinase, which can naturally help reduce LDL cholesterol, and it did. In a follow-up test, I could confirm that this strategy worked. My blood lipids are now back exactly where I want them.

Comprehensive lab testing of the sort that function offers is just so important for health. I mean, how else are you gonna know what's going on under the hood? And while I've been doing blood work for years, it used to be time-consuming, complicated, and expensive. In fact, I used to spend thousands of dollars per year trying to get this kind of data, and the data, frankly, were not all that good. But now with function, it's extremely easy and affordable. A function membership is only a dollar a day, $365 a year. And if you think about the information it provides and the health challenges it helps you avoid and the proactive things that it can do for you to enhance your health, I truly look at it as a savings.

To learn more, visit functionhealth.com slash Huberman and use the code Huberman for a $50 credit towards your membership. Again, that's functionhealth.com slash Huberman. I'm always struck by extremes of personality, but in both directions. So there are these people who just say like, I don't get sick and they don't get sick. And it's super frustrating because I'm not one of these people that's very sickly, but I occasionally get like a sniffle or a cold or something, you know, less and less with each year because I do feel like pay more attention to the sleep piece than I, certainly than I did when I was a graduate student, post-doc or junior professor.

But there does seem to be this quote unquote positive or let's just call it a reinforced mindset as opposed like an immune reinforcement associated with the mindset. Because some people will say like, I just always get sick. And I believe them, they always seem sick. But it could be that you get sick and given an environment once and then you just decide that you're sickly. So then, you know, it could be that the immune system is listening to these thoughts, but not in the form of words. I think this is where like it gets hokey for people, like real biologists and physicians are like, yeah, you gotta be kidding me.

Like, but, because the immune cells don't listen to thoughts, they listen to brain states. Triggers of some sort. Triggers of some sort, right? And then there's like, as humans, we have this obsession with language that makes it seem like you can, you know, write affirmations and then it's the word content, but it's the feeling state associated with that, that at a biological level makes total sense. So we were talking about spatial biology and the fact that you can tuck some pancreas in the kidney and unless someone has type one diabetes, a lot of the functions of the pancreas can- Can still function.

Can persist or transplantation of these clock neurons and clearly there are limits to this, but in the context of the immune system, I'm wondering, can we take a little bit of thymic tissue, bank it and then just later like, put it in a slow release capsule under our skin of our hand? You know, like, and that might sound crazy, but I have friends, one of whom might be at Neuralink now, who actually embedded a little radio receiver under his hand to be able to open his locks at his home and his car and his wife might have one also. And like, that might sound really like Bay Area, like future tech, kind of wacky biohacking.

But if I knew that I could be much healthier by taking a few thymic cells and, you know, sterile capsule and sliding it under the skin, you know, people get their ears pierced with less invasive procedures. Why not? Well, I mean, the question is, why would that, is that likely to work? You're basically, remember how we were just talking about, if I do 10 experiments, one might work. Yours isn't a bad idea, but is there, it's more than likely at one of the nine out of 10, I would guess. Sure, but is there a correlate from any studies on animals?

We know that in a lot of studies of cancer and tumors, I used to see these mice down in the vivarium, they would slide tumors under the skin and study them and give animals drugs or give animals stuff. Very, very common. Yeah. Tumors are happy to thrive in novel environments, so why wouldn't healthy cells? No, I think you can. I think one of the things that comes into play a little bit about that, that's more about replacing an organ with one that might be better, is that at some point if you come in... So one of the challenges of tissue engineering is if you want to bring in new genes, the The vector, the material, the surrounding, whether you're using a virus to bring it into those cells that you're going to now put into the person, whether it's a virus or a small piece of DNA called plasmid, you effectively are giving that a new bit of identity.

And when you go to transplant.org and back in, it's seen as foreign. And it's just like you just put an infected cell in you. As far as the immune system knows, all of a sudden there's a cell with a huge number of new things being expressed. and some of them viral, literally. So that represents an issue, I think, when we talk about any kind of sort of engineering at the moment is if you engineer a system to be maybe better, the immune system isn't necessarily going to want better. And so you have to overcome this issue of tolerance maybe at the same time.

And again, that's why that particular experiment, depending on what you're putting under the kidney capsule or whatever, it matters what the immune state is and what that thing is as to whether your immune system is gonna let it fly. I'm not considering doing this. I just, I think we are, I don't know how old you are, but I can guess based on some mutual friends we have, but I'm guessing that a lot of people who are able to understand speech, they're old enough to understand speech, are thinking that in our lifetime, we are going to be able to use our own cells or peptides, or synthetic versions of peptides from our own cells and so forth to overcome a lot of the issues that our parents and grandparents were not able to overcome.

You know, with regards to like the peptide side of things and even the cells, and this is maybe where you're going with space, is that context does matter for the immune system. So, and it matters for all biological systems. I'll just give you an example. We did a study of wound healing some years ago. And if you have a wound in a mouse, it's maybe just a, like, you know, if you ever have a melanoma removed, do a punch biopsy, it's a little circle. So you can do that in the back of a mouse and then you can watch the wound healing happen. There's zones within there where certain biology is really important to be happening. So imagine the wound is like this and it's open. The cells, one layer back are doing certain things, but the other ones behind that are also induced to do something. The wound isn't just this area. It's actually sensed all like a gradient, almost like in the neurons. And so these cells need to do different things than these cells.

So if you wanted to administer some, like a peptide or even just a cell type, you have to be a little bit conscious of like where it's going to do the work you want it to do. And the natural system does that naturally, like the cells on the inside actually instruct the cells one layer back, but you don't necessarily want everybody getting the same signal. So like development happens that way, you know about gradients and we were talking about this earlier, that there's gradients. So I think one of the tricks that we don't really understand about this is when is something good for a process.

And when is it only good when it's given the right dose at the right time? And I think that's one of the tricks about some of these things. And again, that's where, you know, both in the lab and, you know, like I would say that more so than ever in our lives, you know, we're seeing, you know, people kind of like experimenting with things on themselves. And one of the sad parts about this, we don't capture a lot of data therefore, you know, cause it's not seen as a study and we can't say everybody that took this gets this result.

And then you have this rise of things the internet of anecdotes that become seen as data, like, I took this thing and this happened. And that's, you know, I could drink this drink and have something great happen to me or something bad happen to me, but it might have nothing to do with the drink, right? You know, that issue is one that I think is really critical in this window of time right now. And honestly, I don't know what to think about the idea that people, you know, do experiments on themselves. I think we all want to improve ourselves. We all do some kind of experiments on our side, we're like, you read a book, you're trying to improve yourself, right?

The physical one gets a bit tricky when you're not sure whether something's gonna be dangerous or not. Oh yeah, and I'm not promoting that people do this. I think that, of course, one would wanna see preclinical, clinical, and other trials for this. I think I would personally. I mean, just- Yeah, I mean, there are a few areas where I am a bit more adventurous, but for the most part, I'm like, you know, based on my training and background, I have to orient toward, you know, I'd like a bunch of, let me put it this way, I'd like a bunch of other people to do it first.

It's fun to be first unless you're doing something really stupid and that can get you killed, in which case, let other people go first. I think a good example of that right now is, and this is nationwide or even international, is vaccine hesitancy. I know this is a touchy topic, so we can feel open. No, but you can feel open. Well, I'll just point out that one group that's completely, no matter whether they're hesitant against childhood vaccines and the number of them we get and the fact that the government makes you take them in these sorts of things. If those people have cancer, they're very interested in vaccines because there's really good data that you can promote more immune cells against the tumor by making a vaccine that consists of some of the proteins and peptides that are unique to the tumor and not different from you, and you introduce those as if you would introduce the virus or anything in a childhood vaccine, similar concept, just different peptides.

or peptides from the tumor. And in those situations, it's context, right? So if you and I had cancer and we don't have the conventional cures, they're not going to work on us. There we know statistics really well. Chemo is not very good for a lot of cancers. That's the only thing we got. But if you have access to something that's relatively new, and particularly vaccines, despite what some people worry about, they're pretty safe. And so the certain dye versus tryout of vaccine drives a lot of people to be interested in vaccines. And I would say, yeah, in that case, It's a really, you know, you can see where people's, their question about whether they're gonna try something or not is very context dependent.

Very. I think I don't wanna go too deep into the vaccine debate and I don't wanna be a spokesperson for either side because that's not my role today, but I think that what you referred to as vaccine hesitancy actually comes back to an earlier issue that maybe you'd be willing to comment on, which is I think there are a very large number of people for whom they are neither anti-vaccine nor super pro, but they're asking about timing and combinations. They're saying, okay, listen, and we had Jay Bhattacharyya on here, and I've had several others who've said, maybe there should be an investigation of the spacing of these things, how many, how critical it is to do at a given age, you know?

And on and on, we could pick any vaccine for that reason. And as an immunologist, Do any of those questions make sense to ask? I mean, I could see how, you know, bombarding the immune, the young immune system with a lot of vaccines is a very different thing than spacing out the delivery of those vaccines. I'm not saying don't give them all. I'm saying over what time window does one give them? I think a lot of people, many more people are asking that question. It's just a quieter murmur than are saying, listen, we don't want to take any of these things.

We don't want our kids to take any of these things. I wonder if there's a tune. I think there's some fair aspect to which most of these vaccines were not studied in the context when they were studied of what it does in combination and in these sorts of timings. The fact is that the evidence that there's bad things happening doesn't look to me tremendously strong. It's almost like anecdotal sort of information. Unless it's your kid. Unless it's your kid, in which case you're going to look for an explanation. So I don't know- Right. Yeah. Just being fair, as long as we're admitting psychology as a factor.

Yeah. Yeah. Yeah. So there's fairness on both sides of that discussion, and I think that almost certainly where we are now, there's probably ways to put together vaccines and certainly more convenient ways. As a parent, I actually had something very similar where I delayed my first daughter as one of her vaccines, partly because I know that there's a certain element to which when we design a protocol. The protocol for immunotherapy of cancer for patients was actually based a little bit on the mouse work, a lot on the mouse work that I did. You can imagine that mice and humans are quite different, but that is the protocol. The protocol is protocol and that's how it's done in medicine. And that's because you have a fairly good sense of the safety of it because of statistics. But that isn't to say that it's the only protocol that would work. And I think you're getting at this concept of like, could there be at least a more convenient one and also one that's safest or even one that is less disruptive to the lives of the children and the parents.

We delayed one of our kids' vaccines by just a month or something because she had not been feeling well, just straight up. It is true. I'd say that a couple of the vaccines that have come out that I've had recently, the shingles one is a good example, that has knocked me completely out, and it's very, very heavily adjuvanted. It's clear that it's happening. Does it need to be? I actually don't know. I don't know what studies were done. There's kind of an aspect to which, I don't know that we're all being shielded from the information, but I don't know that we all know how to read the information about how these regimens were chosen.

Some of them are chosen by competing pharma companies that each make their own materials. And again, I think there's a lot in this question. I don't know how much of it also represents the one problem of science that I could talk about is this issue that a lot of science treat. sciences are kind of a papacy. Like we know the language, we know the facts, and we probably don't have time to tell you why we think this and where the holes are. Excuse me for interrupting, but you know, a huge basis of this podcast is to counter exactly that. I know.

I know all these incredibly smart, incredibly well-meaning people who have lives of their own, health lives of their own, health challenges of their own, kids of their own, and on and on, and no one was hearing from them. It was, and as things get more politicized, there's less incentive to give nuance. I actually really appreciate you providing some nuance on the, I mean, it's clear where you stand on vaccines generally based on what you've said, but you're offering perhaps the opportunity for better understanding and certainly delivery of the information. Yeah, I mean, it's a huge problem. Well, I guess it's one of those ones that I can only speak about what I did as a human.

When I had kids and I looked at the data And I have probably better capacity than some anyways to read it and look at risk versus harm. You know, the percentages of these things. I absolutely, you know, vaccinated kids and that was, it seems like, it seems even now like a reasonable no-brainer. But I just told you too that I asked to go off protocol because at some point I know these protocols have a little bit of like, again, they were designed on a one study. It doesn't mean that it doesn't work if you wait another month. In fact, if you do, if you've done enough mouse experiences, I have, you know that when you vaccinate on a slightly different schedule, you can still end up with the same outcome that is protection with slightly different schedules.

It's not that convenient for doctors and hospitals and even sometimes for patients to get off on like weird schedule and then you forget a dose and then it isn't as effective, right? So there's efficacy that comes with trying to follow the protocol and because the protocol has some convenience built into it, that means you're going to do it. brushing your teeth in the morning, you do it in the morning, the evening, so it's when you do it, and so you'll do it twice a day. So there's a lot in this. I mean, there's a lot of politics, I think, involved in vaccine two that relates the question of like, at what point can the government tell you what to do, which is, it's a surrogate question to the vaccine one, where a vaccine is, if there's a harm, who gets to choose with the harm benefit, and then how resources are given out for schools. We know all these nuances. From a science standpoint, I don't think you want to wipe out the baby with the bathwater. I don't think you... Personally, I wouldn't not immunize my kids. Could there be additional studies about the combination of these into fewer shots? I think so. I don't see why not.

Here's where you get the financial rise. What's the benefit to any pharma company of doing that? Well, I think this is... Again, I have to be careful that I don't place myself into an advocacy group that I'm not, I'm, I look at everything on a case by case basis. I tried to do that. I really tried to do that. But the, you know, and I've tried to be in recent years more open to the, to at least understanding what the anti big pharma stance is really about. You know, it comes up a lot around SSRIs, but you talk to somebody with clinical grade OCD and they will tell you that SSRIs saved their life.

So then you go, okay, well, you know, so we can say all we want about pharma. Are you talking about people taking insulin or, you know, until recently the GLPs were mostly available through pharma now, they're sort of, it's kind of the wild west. People are microdosing them from all sorts of compounding pharmacies as their own issues and so on. But my sense is that the frustration around the kind of dictatorial, like you're going to do this at this point because this, or else like your persona non grata, that kind of people being shunned in both directions, in either direction rather, that's really the source of the problem.

There really hasn't ever been a conversation quite like this, at least not one I've seen publicly. Yeah, there are not a lot of labs that are going to devote themselves to this. People will wage the argument that, and I don't know if this is actually true, but that the pharma companies are protected against lawsuits about vaccine injuries. Yeah, they are. I think that probably is frustrating to very frustrating, excuse me, to a parent whose kid seemed essentially fine, got a vaccine and three days later started exhibiting symptoms that then set them off on a course that was really, really tragic.

And those groups are the ones that have accumulated the most oomph out there. And if you think about those parents, it's totally understandable why they would feel that way. Whether or not the basis of their feelings is exactly right. I can't speak to, but you can understand if your kid is one way, walk out of the doctor's office is another way, and you can't do anything about it. That's gotta be, I mean, beyond madness. And the question is what could you have done differently I think is in those situations, having been in them, not that exact situation where you said, oh, now it's done and now I can't go backward.

And you did that to them. This is the thing that, what this is the thing I think that is not often discussed is that the parents made that choice on the basis of what they thought was the best. So there's a certain guilt slash anger. I mean, there's a whole psychology to it that's completely understandable. The kid didn't wander into the clinic. Yeah. Well, I mean, on the way over here, I was thinking about some of the things that are happening in medical space. You guys have obviously from time to time talk about peptides and these sorts of things that people are using off late.

Well, not even off label, they're just getting them from wherever, the internet. And I was thinking, there's a funny thing there because the legitimacy of pharma companies has sort of fallen into even worse straits than before, because I was thinking about this, a lot of it does relate to the fact that we are advertised to take a lot of things that often aren't ... The side effects are worse than the symptoms that we were leaving. That sort of ... Again, I may find myself having a bunch of colleagues hate me for talking about this with you, but I do think it's kind of important at some point to surface where all this comes from.

The idea that we can do experiments on ourselves, on our own bodies, again, it's quite different to say read a book, although you can be infected by, we believe, like by scripture and things in your behavior. But somehow in here, this idea that we can be told to do things by people that aren't quite in our best interests, I think it opens up the idea that, well, why can't I choose my best interest? You know, who are these experts that I can't always trust? What's more American than that after all? Well, it is. It is. It is part of the pioneering spirit. If the government's not going to protect my 40 acres, I got to have a gun and protect it myself. And that's been a part of our culture for a very long time. And I think this idea of individuality plays into this, but it could be exacerbated at the moment by the fact that there haven't always been good communication with somebody you're trying to work out. And maybe even surfacing these ideas that are hard to talk about, like should we trust farm companies? I know a lot of people that work for pharma and they really, they are doing good. They're like you and me. They really think and they are treating disease. They're making really good drugs and they do really good things. But it's not always true. Just because a bunch of people, and it's not always true that the subtle best interest of a corporation is the same as the best interest of an individual.

So we have to surface as those things exist. It's not like we have to say that it's right or wrong or whatever, but at some point those kind of perverse incentives exist. I wonder why pharma companies haven't gotten better tests for who's going to respond to these checkpoint drugs that we made. We've had a few papers that show who are the responders and who are not, but it's still the case that if you get to come in with melanoma, even though there's only a 50% chance you're going to be cured, which is great, you used to be zero with these drugs, 100% of the market takes that drug. Well, because the 50% that aren't going to respond, they don't know who they are, and so everybody takes it. The companies that sell those have no incentive to develop a test, although if they develop a test that shows who is and who isn't going to respond, they'll cut their market in half.

I don't think any pharma executives out there are going, eh, but there's no positive incentive to do that study, to study those things, and I think it's kind of true in some of these other drugs that we've been brought forward, some of which are better and worse than others we could tell that this is going to be good for us and we should take it, and again, you're You're getting to the American mentality, which is to say, well, at some point, if you fool me twice, or I'm not going to believe it, and I might not believe it against an entire spectrum of things called science.

And the problem is that there's people like you and me that are trying to actually do, and most of us, I'd say 99.9% of us are working our asses off to figure things out and discover stuff that's important for mankind. And then you have these issues that arise, and you're like, well, then should you distrust As a species, should you distrust the entire class of science? Probably not. You just need to maybe make it so that knowledge is freer and knowledge is better communicated and that you do watch out for those situations where there should be... And maybe vaccines are one...

We just need to do something sensible like what you're describing and just to do a study and say, let's do that study and make that very public that we do it and say, we're going to do that. And obviously, people can sign up for ... You can have this regimen or the old regimen or the new regimen. I may be speaking, I don't do vaccines. It's not what my lab studies, but there could be some sense to saying, well, maybe science as a whole could take this on and say, what would be ... Maybe the answer isn't just say no vaccines.

We think they do ... There's good evidence that they're protective, but to the extent that you're coming out, could we make it less ... Let's do it and let's just do it. Let's do that experiment. See, that's one of the things that's not happening right now is that nobody's actually describing an experiment. What would be the experiment? Yeah. Well, the discussions haven't happened, and I should say a couple of things. First of all, thank you for going to venture into this area. I seriously doubt that any of your colleagues are going to be upset that you're having this conversation. I will make sure that anything we put out is in context.

If anyone cuts a clip, I will be the first to dive in there and say, this is taken out of context. But to any people, colleagues or otherwise that would say, hey, actually this is the wrong stance. You don't want to be talking about nuance in a time when there's so much threat to traditional medicine and vaccines, et cetera. I will say this, the idea that you need to push back with just a fire hose of do this or else did not work. The pandemic proved that. In fact, I think one of the biggest mistakes was to have one individual as opposed to a panel of people with more nuanced communicating public health information at that time, any person, scientist, doctor, or otherwise, who thinks that the way to convince people to change their behavior around vaccines or anything else is to just ram it down the public's throat and say, or else you're whatever, you're political this, or you're a fascist or whatever, okay?

That is proven to be wrong. And the path forward is really this kind of conversation. It's highly educated people like yourself, educated in the immune system, who understand this, who have children, who've made certain choices saying, yes, and I can understand why you would be considering the following questions, and we should do a study. And in the meantime, you're not preventing anyone from getting vaccines. There's now hunger for more nuanced conversation around these things. And I think it's the right time to have it when we're not in the throes of a pandemic yet. I mean, there's some things that are on the rise.

It is scary. I'll be quite blunt that the rise in measles is scary. People say, well, measles, they used to have measles parties. Talk to somebody who had massive inflammation and brain inflammation from measles, not a pretty picture. Not a pretty picture. So I think it's great that these conversations are starting and it won't be taken out of context. Yeah, well, I mean, on the vaccination front, I mean, I just wrote a little sub-cycle also about the origins of small vaccination And I think what's lost in those stories is if you look on the internet, the absolute net that's a terrible disease, the reality of what we're protecting against, it's really hard to also have that conversation without doing a little bit of reading into your history.

And I don't think the history books are pulling the wool over our eyes by saying some of these things were really horrendous. The smallpox was dreadful. So there's an element of that though that I think that we have to make sure that the conversation focuses on what are we trying to achieve here? And sometimes that question can get lost, but I think, man, if my kid got smallpox or got measles or got muffs, and as we know, measles is not a theoretical. Again, that concept is enough to say, well, there is a risk of that, and that's one where you, it's like you're not teaching your kid how to cross the street properly.

If you didn't do that and then the kid got hit by a car, you'd just be decimated. So just because we haven't seen these things for a while, doesn't mean that they're not still real. And I think that's also an important, and that's me as a parent. And I did look at the history of these things and they really are bad. And so we are defending against something, but is there a better way to do it? You propose experiment. That's, I think there's a, cutting off the concept of human curiosity science at the legs is probably not the way to figure out something out.

From my experience, you dive in, you think of the experiment that will answer the question and you say, well, is that the killer experiment for this thing? Again, I think you look at the numbers and the numbers for my, this is me as a parent looking at the numbers of the danger of bad stuff happening versus the odds of an adverse effect. They were all that high. You know, again, if you're one of the people that, even if it is that, even if it is caused by a vaccine, which I don't, by the way, can I tell you a little story?

Please. Maybe you know this already, but if you want to induce autism and mice, people do it by injecting a bacterial infection into the mom when she's pregnant, which tells you that an immune challenge can affect the neurons of a developing pup. So it's not outside the realm to say that in some situations, in an adjuvant situation, Again, I may regret saying this because it's going to open up a conversation to have this, but it's not outside the bounds to say that an immune insult will have influence on neural development, period. Is it the source of autistic children, or was it in fact that the mom had infection during pregnancy?

It's not absolutely wacko to think, and you should think this is a neurobiologist, I think you'll probably agree, to think that inflammation, some of the molecules of inflammation will affect the cells of the brain. Yeah. In fact, one of the best experiments that I look along these lines, it's not about autism at all, but it's about when you get a flu, you tend to feel like you want to socially isolate yourself. At least I do, and most people do, I think. They kind of want to crawl in a hole, crawl in a hole field. There's an experiment that was done that involved injecting gamma-nirphuron, which is one of the things your immune system makes when it's fighting off an infection, into the blood trick of a mouse, and then just watching it.

And they become socially isolating from just the molecule that's made by the immune response during infection. Not even from being sick. Not even being sick. They're not sick. They're just are given this cue that's part of the systemic immune response. And then they show the signs of social isolation. And the lab that did this also showed that the brain has receptors for these immune molecules. You know, the simple conclusion of that paper is, you know, there's still always work to be done, but simple conclusion was that the brain could sense infection and it would affect behavior, even in mature, in us as mature.

So you know, again, there's these ideas that there's something that, I mean, scientists use that infection of a mom to lead to neuronal changes that lead us to be able to study autism in later mice. So there's definitely potential there. I don't know that the vaccines and all of them, or whether it's a circumstance or whether it's getting the mom actually had a fever before and the vaccine now just triggered, or it didn't, or just circumstance because you give vaccines at two years of age, which is when autism appears. There's all kinds of options and those sort of anecdotes of that.

And I just think that that fact that the way that we study autism is by giving a pregnant female mouse an infection And it's sort of like, okay, that's important to know. That work is still ongoing by laboratories to understand autism. They want to understand the origins of it. And maybe it will not turn out to be vaccines at all. Again, we need data. And we're- We definitely need data. We're almost in a COVID situation. I just described the COVID situation now in retrospect as one that is data spars. And this is why I've been trying to work on, I was telling you about this project of trying to work on the publishing problem.

It's not just the publishing problem, it's how we synthesize knowledge that under data sparse circumstances to make decisions, I think we're not very good at that societally. When we have tons of data and it says, absolutely, if you have cancer and you take immunotherapy then there's a 50% chance you're going to revive, great. Those stats are solid, they're very good and I would take that drug every time. But if it's sort of a case where you're like, no, there's some things that are happening and some other things that happened, we don't know. You remember the beginning of COVID, we talked about it amongst ourselves in labels and we were coming in to analyze blood and it was kind of unsafe because we didn't know what was safe.

We didn't know how it was transmitted, we didn't know anything about it, could we get it from blood? And that kind of went on for a while, right? And this was the source of a lot of confusion that came from the medical, it seemed as seen as confusion in that matter of fact, it's like, do you mask, do you not mask, do you not touch, do you not touch? I think that's a data sparse situation. data that we had was sparse. It wasn't a lot of information. And so, how do you make a decision when you don't have a lot of data? Well, I think that's the major argument. When there are people that will critique people saying, okay, your experience is ANAK data, it's correlative, but then with regard to vaccines and autism and other issues, but then the pushback is, well, this vaccine, et cetera, was directionally guided by sparse information to begin with under times of pressure, there's financial incentives.

So it's just this ping pong that goes back and forth, but many thousands of parents write to me and say, should I wait on certain vaccines? And I'm like, listen, I am not the person to answer that question, but you have every right to ask your doctor, right? But they're not asking because they're extremists. They're not anti-vaxxers. They're asking because they love their kids and they've seen enough things to call into question the incentives. And they just know that the conversation cannot be as polarized as it's presented to them. in reality. The data cannot be as polarized as it's been presented.

Yeah. Certainly in media, some of these things get presented quite inflammatory. And again, if newspapers want to sell a newspaper, they show a plane crash. So it's not happening every day. Yeah, but they'll show you an airline ad in the same issue. Well, there's that too. I think one of the interesting things that we could get into is that in a lot of these studies, scientists are, there's a motivation to make the most of your result. And we've talked about why that's important is that if you find somebody orthogonal, CRISPR, checkpoint blockade, X-rays, you look for that orthogonal use for it or that orthogonal meaning. Sometimes we call it extensibility. I see that if I drop coffee cup on the thing that gravity pulls it down, well, then I can drop all kinds of things. I can make gravity work for me. It becomes a tool. And I think one of the things that is lost sometimes is that some things are not extensible.

So you can imagine that if I had something that makes a cell move, that that might screw up the whole system forever. But humans and our bodies turn out to be remarkably resilient. I mean, we can go from minus 20 degrees to 110 degrees. We can not eat for a long time. All these things don't cause us to fall apart. So if we didn't have resilience, I think our species wouldn't exist because there's all these pressures and all these varieties of life under which we lead. And I think a lot of science sometimes doesn't ... From the outsider, even as an insider, you can read a paper and they point to why it might be important.

But they're really doing that to garner interest for their story and then say, this might be important for this, but I haven't shown that it's important for this. They don't say that it's important as it might be important, and they're trying to look for that orthogonal or that extensibility of it. And I think that's kind of important also just to go a little bit off this topic for for a moment in how we think about drugging diseases as we go forward. And that is to say, we've looked for these one and done drugs that you take a pill and it cures everything.

Forever, that's sort of found abuse-ish. And we found a few of those. I'd say check one blockade is one of those that you can take it and 50% of melanomas, everything, the tumor goes away and everything's great. But most biological systems, if you have one button to push, they're super non-resilient. A virus can exploit that button, you know, that can cause collapse. And so most things are wired like in these really complicated ways. And I think what a few of us are thinking, this is for cancer in particular, where you want to get the immune state from like, remember we had a little concept of a fuel gauge.

You want to get it from one position to another position. It may not just be about a push here. You may have to push some cells that way, create some new environment that looks like development. through states. And you push the biological systems to reach this new state in a way that doesn't look like the linear between low immune reactivity and high reactivity, you might have to push it in a series of ways because resiliency, the systems like even in chronic disease, but even in health, we're pretty resilient and you can stand up to a lot of stuff. Can humans do that even in the context of abundant funding for basic research?

And what you just described actually be tested to the point where we can develop things. And the analogy here is, I had my dad on the podcast, he's a theoretical physicist, and he explained to me that one of the most important things you learn in physics is that you can't really understand quantum mechanics using your logical brain. You need the math to prove it. And this is when, whenever somebody, he also warned, whenever somebody says they understand quantum stuff, you have to ask them to demonstrate it for you because these people talk quantum because, and we make all these assumptions about quantum.

They talk about quantum fields, so we think they're smart, but theoretical physicists and therefore engineers develop all sorts of incredible theorems and real experiments and then technologies based on all of that because the math works, not because we can conceptualize it. And I wonder, given the complexity of biological systems, perhaps in 2026, we're running up against this barrier where by virtue of the sociology of science, that papers need to have one, maybe two take-home messages. By virtue of the fact that there's a limited amount of funding, people need to sleep at night and on and on, that doing the kinds of experiments like you described, like pushing the cells this way, nudging them that way, and then drugging the outcome in a way that is beneficial but not detrimental, is this a place where machines are going to be better or at least helpful in doing these experiments.

I take the standpoint that AIs, and I think this is backed up for talking about AI experts, it's really quite good at producing stuff that is in the corpus. The corpus is the knowledge that we already have. Almost by definition, when you're coming at that with or something discovery, you're discovering something, it doesn't exist in the corpus. You might have hints of it there, but you still have to do experiments at some point. So if I'm going to get an answer to the question you're trying to raise, if I get a tumor from a patient and I take apart all the cell and I look at all the genes that are expressed in all the different cell types, I can build in silico a network where I can look at how all those cells are wired together now.

And I can ask, what would be the possible consequence of clipping this molecule's ability to touch that cell? That's now doable, but it relies on an area of math that's not really AI, it's called machine learning, and sometimes these things are conflated. learning is basically looking to say, what are some of the relationships that I can discover about the relationship between this feature of the cell and this other feature of the cell? So it's learning about it, and then it allows you to propose a bunch of experiments, but you still kind of have to choose and select which ones you're going to do.

Some experiments are just really expensive, and that's where you have to have, I think, still human judgment that comes into that and say, am I going to spend a year studying this question, or am I going to study a little bit more and try to understand some things in a greater detail than maybe the machine learning gave me, but it's not clear to me that anywhere right now we can say the corpus of knowledge doesn't have a bunch of examples of cures across from treatments and say, oh, all I need to do is match those up, which is kind of what AI does when it comes to large language.

You query it, it looks in statistically and says, what are the relationships between what you query and what I give you back as an answer? In a discovery space, we don't have examples of the other end. Sure, I can tell you all the things that you could do, but knowing which one is going to be orthogonal, big hit isn't there, but what I'm talking about a little bit is to take a problem apart and say, if I have something like I want to change something and anything, this could be if I want to change the world. It's unlikely that when you one act will do it, also the world is pretty early.

systems, despite what we think are somehow semi-stable. But a series of these nudges can create the condition where the last one takes you across the border. And I think that's what we're going to have to do in disease, where we say, look, nature doesn't necessarily want us banging on it, it'll bang back. What in effect we need to do is, if we want this tumor to get heated, we need to first let it not look like it's a wound that's healing, so don't give it the power of the immune system, the positive power, and then get to the point where we can say, well, now we want it to teach the immune system to kill it, but we might not be able to do that until we kind of dissemble some of its defenses.

That's a way of, again, in this kind of deep computational space, we end up with a lot of feature of tissue cells and how they're organized and what genes they're expressing that start to look like Magellan's map of the world that in its early phase, it only had parts. Then it starts, as you explore and you add things to it, I think when we start to think about how tissues are configured, we're starting to be able to see these really complicated states where the immune system is doing this and fibroblasts, certain cells are doing this and epithelial cells are doing this, and that's a... We call them archetypes. They're like a way that biology organizes itself. And to get from one to the next, we need to understand how it does it developmentally. That would be a really nice thing to follow. And then we need to give those cues in order. And that's where I was coming back when you were talking about peptides earlier and saying, well, some of these drugs may well work, but I might imagine that they might work best if given in the right sequence and the time and the place.

And that that's when you really want to hammer it to get the system to go to that, but then it might be connected to another one. And we all want to find the one thing that the fountain of youth, the thing that cures the disease, and it's been forever that we've been looked for a single, single hits, one and done. But it may be a collection of ... And this is probably ... This is how I live my life for health is a collection of behaviors and food you eat and sleep you get, and all these things create partners, you know, the loves of your life, the friends you have, they're all part of, I think, and that's getting a little away from immunology, obviously, but it's an analogy.

No, but when you think about the insula, you know, not so much, a good friend of mine who's a physician in the Bay Area says, you know, better living through chemistry still requires better living, which I love because it says you should never abandon as much as one can the foundational stuff of sleep, exercise, nutrition, circadian rhythm, light, social connection, stress mitigation, and on and on. Could I ask you a couple of additional questions about the immune system before we wrap? Because I know many people are curious about autoimmune issues. More and more I hear about, I don't know, is chronic fatigue considered an autoimmune issue by most?

A lot of people seem to have chronic fatigue. There was a debate, does it really exist? for someone who believes they have it, it absolutely exists. They're tired, I believe them. I know someone who had a myalgia recently. Psoriasis is something that I maybe have known to be now autoimmune. Asthma, these are interesting conditions, not all of them life-threatening, but some of them cause a lot of discomfort. What is known about the formation of autoimmune conditions, either inheritance, lifestyle factors, and then what excites you about some of the newer treatments that might be available or are currently available, those and other things?

It's a big question, but... Yeah, it's a big question. Well, fundamentally, again, this is, I think, where the immune system and our bodies have, I think they have playbooks, like a football team or something, that they can run and they can put players in particular configurations. Again, we call those archetypes. The immune system is trying to do a certain kind of thing. It's genetically and through history, it's wired to work with cells in certain ways. And I think if you look at autoimmunities, there's a view of them that they represent a misplaced immune system that's either thinks that it's under attack or it thinks that it's meant to be doing something that it really isn't.

And so the origins of some of those are genetic for sure. There's lupus, there's a familial mutation and a receptor that's on a B cell that normally helps turn off the immune system It's defective, and so those people are susceptible to getting what are called autoantibodies. That's where the B cells, we've talked a lot about T cells, but B cells are the ones that make antibodies, and they're the ones that you try to prove to jazz up for COVID vaccines. Those can be overactive, and they can be genetically overactive, and one wonders why we'd ever have such genes and why they'd be propagated, except that maybe in some sort of circumstances you need it when there's a big pandemic or something.

Those people might have a particularly good response. So there's definitely genetic origins of some of these things. I think what's interesting to some extent is something that you've alluded to with asthma, where asthma was one of these things that historically would be called an allergy, and it still is an allergy, and where you have inciting things that are grass, pollen, these sorts of things. But in a lot of these settings, the concept that is coming in part and parcel with the immune system recognizing self is a thing. And to the degree that we don't understand some of the diseases as well as we should given the tools we have today, there's actually work to be done in a lot of these areas where you say, what is the immune system up to?

Ten years ago, we might have just said, I might have taken a lung of an asthmatic patient who died and cut it and look at it in a microscope and say, oh, yeah, I can really see that there's thickening of the airways and that's why they couldn't breathe. Like I'm saying, now we can go into those and we can look at every single cell and ask how those are wired together. Is there only one form of asthma? That's no, there's actually definitely those seven or eight and they have, and that's why some people are, you know, like can take the inhalers and it works and other people can't.

Some people they're very like chlorine sensitive, they go to a pool and initiates are cold sensitive. So there's variations on what sets up that inflammatory focus and I would call it like an archetype. Some of them have lots of cells called eosinophils, other ones have lots of cells called neutrophils. So asthma isn't just one disease, it's one symptom, difficulty breathing, but it has many different sort of configurations. And I guess I would just say that in a lot of this domain, I mean, we have a study right now that's looking at across a bunch of autoimmunities to figure out whether they have things in common with each other.

And psoriasis is one where you start to see variations, and lupus for sure, and inflammatory bowel disease. And you know this in the clinic because inflammatory dialysis, you asked about drugs, is a good case where there's a couple different drugs that for some patients work really well. TNF therapy, for example, it blocks a cytokine. And some people with IBDs, it's like really bad diarrhea and manifests and very, very painful. You know, some people, so there starts to be classes of patients that have responses to these things. Those drugs are exciting because they say, you can modulate this. But a little bit like the checkpoint drugs, we don't really understand why one works in one patient and one doesn't.

Inflammatory bowel diseases and autoimmunity is pretty tricky too because people will respond to a drug for a while and then they'll stop. And then the doctors just have to do this like whack-a-mole thing where they try one and it doesn't work. They try the next and then it doesn't work. Sounds like psychiatry. It does. Yeah, there's a lot. It sounds like a dead note. No disrespect to the psychiatrist. Psychiatrist. No, but you're trying to- They have a hard job, right? I mean, drugs will work for a while, then they don't work. They don't work. up that never existed before. It's a tough one.

Yeah, agreed. Agreed. So, yeah, autoimmunity is a real thing. It has, I think it's similar to cancer where we're just with cancer starting to understand the fact that it comes in these different immune flavors. And so the drugs that you try to use, it's clearly immune system can do a lot of good work for us. But what you need to do to it in these different sort of archetypal immune systems is going to be different. you just got a different football team out there playing or they're running a different play. If somebody has a mild autoimmune condition, like let's say mild psoriasis, does that, I've read, but that doesn't necessarily mean anything.

I've read that that might confer, because it's autoimmune, that might confer them with a bit better viral and bacterial infection resistance. So there's a trade-off there, like, okay, so scalp cells are like sloughing off. And like, I think it's like interleukin 17 or something now, like the treatment, they have some good shampoos for this. But- Anti-interleukin 17. Anti-interleukin 17. But that individual is maybe better at fighting out other infections. So, you know, given there's a anti-interleukin 17 treatment that works cool, like no flaky itchy scalp, and yet you're more resistant to infection. So you could see how it's adaptive in the modern context and now severe psoriasis can be very disruptive for people.

And people might wonder like, are we really talking about psoriasis? But I think it's sort of an interesting case point for why autoimmunity could actually be useful. It's not always the case, it's like there to give us asthma or flaky scalp. You know, we can talk about there's a lot of disease states, you know, the argument for why we would ever have a sickle cell gene. This is the one that causes people to have hemophilia and it's a lot of Sub-Saharan African people from that origin have this, is that it's actually defensive against malaria. It seems to be the case, so having that, I think this is true in a lot of these situations where the diversity of the human population over time, by having some of these things that make some people hypersensitive to maybe viral infection at the cost of having things like psoriasis pop up or various other water immunities, is the only way that a billion strong population has to move forward.

And I always give this example, because I think it's a really straightforward one. If you take a flask of bacteria and you put them in glucose, which is like sugar, you put it in your coffee, maybe some course, either one, you put them in a simple sugar and you watch the colony grow, you'll get these cells that grow really, really fast. the bacteria becomes billions, trillions of individual cells, but there's almost always some just losers that are dividing slowly. And it's, for whatever reason, the system always springs us off. You're like, why would you do that? Why would the system, why wouldn't just the winners win?

But if you take a little bit of that culture and you put it into Galactos, which is a milk sugar, often the ones that were winners don't win anymore. And it's from the loser pool that the new ones emerge. And this is a case of like, you know, like a crowd fitness that comes from diversity of genes. And so some of these things that makes some of us susceptible to disease are also, as you're pointing out in other situations, gonna be quite good for you. And that seems unfair at the time that you have these kind of bad genes, but like a different day, you would have been happy, right?

So I think there's a lot to be said in that. And that's also why a lot of the things that we look at anecdotally, somebody takes a supplement and it works for them. I mean, I don't know how much you know about this literature, but the differences in urine mined vitamin requirements is gonna be quite profound because the metabolic enzymes we have for the vitamins that we might take in are gonna be different between us. And so these FDA limits, these numbers are averages. Some people may need five times that amount of vitamin X and other people may need a fifth.

And that's- No, I think this is super critical. The supplement world is kind of like Scattershot. Well, I appreciate the rational grounding in all of it. I think the red throughout today's conversation, I think I picked up on, you know, the fact that we covered things like peptides and things like that. And I'm not certain about the peptide question across the board. It's clear some are beneficial. It's clear some are still experimental. I'm just a big fan of more data. And more data collected the right ways and communicate the right ways as the same way with the vaccines and all the rest.

You have an amazing sub-stack. I know that because I've spent time there. No, thanks. Part of the reason we invited you here today is to learn about the immune system. And we barely talked about cancer. I realize we're gonna have to get you back to talk about that. But you've done an amazing job of educating us on the immune system. I really wanna thank you and speak on behalf of many, many people for that never before had somebody presented in the ways that you have. And as somebody who thinks in analogy and likes to teach an analogy, I really appreciate that stance.

What inspired you to get into public education about science and health before coming on this podcast? And by the way, everyone should check out Max's substack. We'll put a link to it in the show notes. It's so thoughtful, so nuanced, so relevant to all the issues that we're talking about, if not directly, then in the general contour and in some cases directly. And I imagine you're going to continue doing this. So what inspired you to do it? And how can we make sure that you continue to do it? Yeah, well, thank you for the call out. It is something I've been trying to work on for about 10 years in it.

It really started when a group of us were hanging around after a conference and we were talking about some of the issues with science and society. And there were many, there's many. We've surfaced a few of them today. But I think something that you guys are working on is the capacity for everyone else to think as a scientist. You can ask yourself, oh, why don't people agree with this data that you show and take the action that seems logical, but then you present it in such a way that they can't ... Two things are important about it. I think one of them is if you present the information in a format that isn't familiar, you're not going to be able to teach anybody anything about what's important. But the other thing is that we spent some time talking about this and we consulted some other folks that are in science comms and we realized the other thing is that If you say you're a scientist, it's not a neutral statement.

Science has a history, and history is stronger than science, actually. There's hesitancy among African-American, for example, to take drugs because of history of Tuskegee, which is like 80 years ago, however long ago, 60 years ago. It's not in their lifetime in many of these people. Part of the realization was maybe part of what we really should be doing as scientists. part of our job should be to figure out how we relate to other humans. And there's a painting of this, and obviously the media and things help this happen because it makes it interesting to have a kind of a nerdy scientist. And you can be a nerdy scientist, I heard you. But also, you're a human. You're a human being. You're having foibles to loves and hates.

Certainly foibles. I have plenty of those. We can get in that off the podcast, but this concept of if we want to relate, if we want to have impact of the work you do, if you want it to be relevant, at some point you have to... Science as a field needs to make sure that it doesn't ostracize itself from people. And I think one of the issues there, let's just use the word ostracize, is separate, is this concept that we speak in our vocabulary that gets very precise. And we forget that if you hear a foreign language and you hear one word that you don't recognize, it throws you off for a few sentences.

And next thing, you don't know what people are talking about. And I think that concept that ... And again, this is where I think bringing it down a level and saying, let's give it analogy, let's give it ... That strikes me as really, really important to the impact that you can have with your science and that science can have in terms of teaching people what we could do better, which I think we all want to do. But if you end up thinking that science is a distrusted, weird collection of people that have different motivations and designs, then you've lost. That potential for it to do good is gone.

So the sub-stack came about it because I was like, I need to write as a person a little bit more and tell about some of the time that you spend on this and why it matters and what it's like to do this work. in some respects, also what it's like to lose in this, which happens way more often than the, it's like a casino, right? In science, you hear the bells and some cool device comes out and it's, but there's a bunch of people pulling the arm, and they're not winning. So I feel like that's kind of an important part of this that, again, it's not the glory story always.

Some of the best-selling books about science are the wins, but it might be more relatable at some point to get all of it. So that's kind of what I was trying to put together. And at the same time, I think the immune system is also just so relevant and so important. And it's got all these different facets and these archetypes and these sorts of things that it's doing that we kind of scratched the surface today. So anyway, thanks for calling it out. I've been working on it for a bit. Well, I hope you continue to. And thank you so much for the work you've been doing in your laboratory and all the people in your laboratory doing that work.

Because now you're the one calling the shots while other people do experiments, but for your advocacy for science and public education, it's huge, we need more people like you, but you've certainly put your own unique signature on it and the sub-stack reflects that. It's an incredibly interesting set of reads and people will really learn. So that's essential, especially in this day and age, but even not in this day and age, science is just really cool. And with all the meaningless drivel out there, it's nice to go to a place like your sub-stack and I'm speaking to the audience now, you will learn if you read Max's sub stack, you will be inspired by certain things.

And I promise you, so I'm saying this intentionally mark my words at some point, somebody is going to contact you that they decided to study the immune system or they learned something, or they explored a novel treatment with their physician in a given unfortunate or maybe even fortunate situation that better their lives. It's incredible what sub stacks and conversations like the one you've been willing to have today and going forward can really do. So thank you so much. Definitely come back again and tell us about cancer and other things because I took us off course quite a lot but I had a great time talking about all of this and I'm gonna be thinking about a lot of it and really appreciate you.

Yeah, well same here, thanks so much. Thank you for joining me for today's discussion with Dr. Max Crummel to learn more about his work and to find a link to his superb sub-stack, please see the links in the show note caption. If you're learning from and or enjoying this podcast, please subscribe to our YouTube channel. That's a terrific zero cost way to support us. In addition, please follow the podcast by clicking the follow button on both Spotify and Apple. And on both Spotify and Apple, you can leave us up to a five-star review and you can now leave us comments at both Spotify and Apple.

Please also check out the sponsors mentioned at the beginning and throughout today's episode. That's the best way to support this podcast. If you have questions for me or comments about the podcast or guests or topics that you'd like me to consider for the Huberman Lab podcast, please put those in the comments section on YouTube. I do read all the comments. For those of you that haven't heard, I have a new book coming out. It's my very first book. It's entitled, Protocols, An Operating Manual for the Human Body. This is a book that I've been working on for more than five years, and that's based on more than 30 years of research and experience.

And it covers protocols for everything from sleep, to exercise, to stress control protocols related to focus and motivation. And of course, I provide the scientific substantiation for the protocols that are included. The book is now available by presale at protocolsbook.com. There you can find links to various vendors. You can pick the one that you like best. Again, the book is called protocols, an operating manual for the human body. And if you're not already following me on social media, I am Huberman Lab on all social media platforms. So that's Instagram, X, threads, Facebook, and LinkedIn. And on all those platforms, I discuss science and science related tools, some of which overlaps with the content of the Huberman Lab podcast, but much of which is distinct from the information on the Huberman Lab podcast.

Again, it's Huberman Lab on all social media platforms. And if you haven't already subscribed to our neural network newsletter, the neural network newsletter is a zero cost monthly newsletter that includes podcast summaries as well as what we call protocols in the form of one to three page PDFs that cover everything from how to optimize your sleep, how to optimize dopamine, deliberate cold exposure. We have a foundational fitness protocol that covers cardiovascular training and resistance training. All of that is available, completely zero cost. You simply go to HubermanLab.com, go to the menu tab in the top right corner, scroll down to newsletter and enter your email.

And I should emphasize that we do not share your email with anybody. Thank you once again for joining me for today's discussion with Dr. Max Krummel. And last, but certainly not least, Thank you for your interest in science.